Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,11728,48,1.87 [0.39-8.94],0.4305602731805897
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,11394,47,1.22 [0.74-2.03],0.4405626816461556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,13455,55,1.11 [0.73-1.68],0.6247764425625045
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,11359,47,1.50 [0.81-2.77],0.1933974909455955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,13386,55,1.23 [0.83-1.83],0.2974287519456829
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,13455,55,1.11 [0.80-1.56],0.5239539148338688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,11717,49,1.08 [0.89-1.29],0.4393963886458569
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,11359,47,1.35 [0.92-1.99],0.1290618562650437
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",13210,53,1.06 [0.79-1.42],0.6953399478278839
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",11468,50,1.12 [0.81-1.54],0.4994905628105355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",11721,50,1.33 [1.02-1.74],0.0360577596624984
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,13407,54,0.90 [0.39-2.09],0.8059242693367823
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,11717,49,2.40 [0.79-7.32],0.1228822891361319
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,13293,54,1.23 [0.76-1.99],0.3923459681835467
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,11450,48,0.82 [0.34-1.99],0.664606232281135
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,11655,49,1.29 [1.01-1.64],0.0397674476677056
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,13523,54,1.09 [0.68-1.76],0.7233379273036742
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,11388,50,1.08 [0.60-1.95],0.795677850921183
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,13570,56,1.51 [0.75-3.03],0.2460388333375539
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,13625,56,0.87 [0.63-1.21],0.4124172384754258
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,11639,49,1.63 [0.85-3.13],0.1434606979783568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,11388,50,1.10 [0.53-2.29],0.8034701903959551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,11359,47,1.54 [0.90-2.66],0.1174419737850507
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",13293,54,0.61 [0.32-1.19],0.1478405563192707
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,11359,47,0.96 [0.57-1.61],0.8663020415318523
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,13260,54,1.21 [0.62-2.39],0.5783097667231338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,13415,54,1.39 [0.50-3.87],0.5341395599222635
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,13523,54,0.86 [0.57-1.30],0.4781413680826686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,11359,47,1.02 [0.62-1.66],0.9444646114946856
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,11401,48,1.18 [0.78-1.77],0.4351494195644253
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,13680,57,0.83 [0.42-1.64],0.5952608023318728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,13402,55,1.01 [0.57-1.81],0.9638657367964848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,11388,50,1.39 [0.84-2.32],0.1999190902269488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,13293,54,0.63 [0.28-1.40],0.2547026527286612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,13437,55,1.60 [0.79-3.21],0.1892335777016377
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,13680,57,1.39 [0.69-2.82],0.3574553831418511
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,13633,57,1.06 [0.46-2.44],0.8889713202257133
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,11655,49,0.70 [0.27-1.79],0.4559959293642027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,11388,50,1.09 [0.49-2.42],0.8293587992059741
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,13685,57,1.92 [0.67-5.47],0.2237085780164964
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,13455,55,0.93 [0.56-1.54],0.782613567963842
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,13293,54,1.03 [0.49-2.18],0.928563077167607
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,11388,50,0.78 [0.36-1.71],0.5340361391560176
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,13554,56,0.94 [0.56-1.58],0.8093850587184114
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,11700,50,0.98 [0.40-2.39],0.9695014427412924
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,11394,47,0.82 [0.25-2.71],0.7501936210444538
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,11721,50,0.51 [0.26-0.99],0.0464868412973421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,13210,53,1.14 [0.66-1.96],0.6414091761808343
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,11450,48,1.35 [0.91-2.00],0.1403312422395644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,13415,54,1.85 [0.91-3.77],0.0908852416542235
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,11450,48,0.72 [0.33-1.56],0.4022684458145871
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,11655,49,0.86 [0.52-1.43],0.5639372028101421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,13581,56,1.16 [0.50-2.67],0.7252381228561185
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,13606,56,1.19 [0.54-2.60],0.6632932629327327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,11721,50,1.39 [0.57-3.37],0.4719414331768237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,13455,55,0.81 [0.45-1.46],0.4840736980446239
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,13523,54,0.67 [0.27-1.65],0.3847605301277859
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,11376,48,1.11 [0.78-1.57],0.5540612733143063
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,11450,48,0.95 [0.65-1.38],0.7694841617989723
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,13293,54,0.98 [0.74-1.30],0.8766055316866397
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,11728,48,1.10 [0.73-1.67],0.6474136433614123
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,13646,56,0.68 [0.30-1.55],0.363129152523087
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,11359,47,1.11 [0.80-1.54],0.5479433908585369
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,11450,48,1.37 [1.03-1.83],0.0311517621167562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AFM,Afamin,11728,48,1.30 [0.29-5.75],0.7312059232157884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,13400,54,1.17 [0.83-1.65],0.3566443193414023
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,11376,48,1.04 [0.77-1.41],0.7969451185975736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,13492,56,1.42 [0.79-2.55],0.2376252636006801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,13063,55,0.92 [0.73-1.17],0.506253137788222
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,13191,53,1.04 [0.68-1.58],0.8625299666019163
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,13581,56,1.03 [0.49-2.14],0.9461612236027858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,13680,57,0.83 [0.55-1.26],0.3922088106998939
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,11717,49,1.43 [0.51-3.96],0.4960508827211576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,13523,54,1.04 [0.77-1.41],0.7866407452064241
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,13523,54,1.02 [0.72-1.44],0.9125229553051836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,11394,47,0.57 [0.23-1.44],0.2364908671067772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,11394,47,1.21 [0.47-3.10],0.6871984407538041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,11639,49,1.21 [0.87-1.67],0.2610181790487562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,11717,49,2.12 [0.78-5.73],0.1396217569034551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,13503,56,0.91 [0.70-1.18],0.4598472162289843
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",11379,48,1.10 [0.82-1.48],0.5294000132110045
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,13210,53,1.02 [0.64-1.62],0.9386599152953876
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,11394,47,1.07 [0.69-1.68],0.7519588637619007
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",13425,55,1.14 [0.91-1.43],0.2407680401572863
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,13523,54,0.91 [0.63-1.32],0.6185250970666698
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",11685,50,1.27 [0.99-1.63],0.0637218410503178
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,11450,48,1.22 [0.37-4.01],0.7458739768795999
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,13210,53,1.09 [0.80-1.48],0.5694107415040466
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,11379,48,1.23 [0.82-1.84],0.3118469250627561
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,13293,54,1.24 [0.87-1.74],0.230582001199041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,11388,50,0.89 [0.60-1.33],0.5715922704372925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,13183,55,1.08 [0.76-1.55],0.658126644336704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,11703,50,1.24 [1.00-1.54],0.0514250230476054
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,13142,52,1.04 [0.68-1.60],0.8514498378806151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,13685,57,1.75 [0.53-5.74],0.3574559007139413
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,13524,56,0.67 [0.41-1.07],0.0954097155804517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",11639,49,1.18 [0.77-1.81],0.4463361207687925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",13493,56,1.22 [0.89-1.66],0.2093033722733685
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",11703,50,1.61 [1.03-2.52],0.0362694150780393
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,11468,50,0.40 [0.19-0.88],0.0223950155277712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,11388,50,1.04 [0.84-1.31],0.7009876660760599
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",13455,55,1.16 [0.94-1.45],0.1726382502512864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,13260,54,1.48 [0.90-2.43],0.1198403512000188
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,13630,56,1.13 [0.33-3.85],0.8455598122127401
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,11700,50,1.47 [0.50-4.34],0.490112507865948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,13183,55,1.27 [0.95-1.71],0.1087036022417947
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,11379,48,1.06 [0.64-1.75],0.8254724706063676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,13455,55,1.78 [0.61-5.16],0.2891463562285282
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,13260,54,1.09 [0.67-1.77],0.7171322360768861
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,11450,48,0.76 [0.39-1.48],0.420682800339259
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,11612,49,1.13 [0.66-1.91],0.6593951116605702
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,11685,50,0.86 [0.60-1.24],0.431917125524626
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,10979,46,1.12 [0.63-2.00],0.6894128605663592
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,13008,55,1.18 [0.70-1.99],0.533701088409237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,12596,52,1.22 [0.72-2.07],0.4515402562275095
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,13443,55,1.70 [0.95-3.06],0.0764299021203651
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,13479,55,1.18 [0.89-1.56],0.2511601691885332
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,13646,56,0.68 [0.37-1.27],0.2307340401581219
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,13338,54,0.73 [0.32-1.66],0.459504116343059
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,13543,56,1.79 [1.00-3.20],0.0513453211388785
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,13494,56,0.90 [0.47-1.72],0.7482811476637201
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,13560,56,1.14 [0.69-1.89],0.6119860991396722
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,13646,56,0.99 [0.52-1.87],0.9673014004273064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,11359,47,1.09 [0.76-1.57],0.6363474402986182
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,11388,50,1.50 [1.09-2.08],0.0140271878818124
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,11296,47,1.33 [0.87-2.02],0.1906088206260423
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,13210,53,0.70 [0.43-1.15],0.1639444089710438
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,11394,47,1.75 [1.27-2.43],0.0007105484937185
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,13502,56,1.46 [0.67-3.20],0.3429442346011581
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,11370,47,0.64 [0.32-1.29],0.2100378406054756
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,13183,55,0.93 [0.68-1.28],0.6674078299423778
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,13490,56,1.12 [0.78-1.62],0.5348774037575743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,11220,46,1.20 [0.84-1.72],0.3169319290643032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,13633,57,1.10 [0.80-1.53],0.5544372144115103
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,13450,54,1.15 [0.83-1.58],0.402811380006736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,13145,55,0.64 [0.28-1.43],0.2779502621976405
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],13260,54,1.31 [0.96-1.78],0.0902566850926814
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,13533,56,1.41 [0.65-3.05],0.3885614759194293
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,11639,49,1.22 [0.89-1.69],0.2164453530521321
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,11379,48,1.38 [0.89-2.14],0.1472793873463743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,11655,49,1.43 [1.02-2.00],0.0386185167228608
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,11685,50,1.87 [1.15-3.04],0.0117554726436686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,13455,55,0.67 [0.37-1.22],0.1902822096326429
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,11627,48,1.15 [0.54-2.45],0.7260407466535194
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,13606,56,0.78 [0.52-1.18],0.2439584599529953
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,13523,54,0.86 [0.54-1.38],0.5435700059024415
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,11728,48,0.98 [0.37-2.60],0.9694343913561904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,11717,49,1.69 [0.96-2.97],0.0678802960597703
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,11728,48,0.97 [0.46-2.04],0.9290286884266354
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,11717,49,2.73 [0.74-10.07],0.1318306853759173
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,11394,47,1.03 [0.54-1.97],0.9351614218350416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,11701,48,1.85 [1.06-3.23],0.0299317120989948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,11164,45,1.24 [0.76-2.02],0.3864661803586868
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,11728,48,1.13 [0.86-1.49],0.3888902378104244
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,11717,49,1.00 [0.37-2.69],0.9948317161943542
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,13524,56,1.06 [0.55-2.05],0.8615349247172908
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,11717,49,0.99 [0.66-1.48],0.9681616422515824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,13515,56,1.76 [0.72-4.26],0.2129475840544948
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,13498,56,1.16 [0.83-1.63],0.3908819427133011
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,11450,48,1.16 [0.90-1.49],0.2396826524980337
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,13419,55,0.89 [0.55-1.44],0.6304895469085441
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,11468,50,1.14 [0.79-1.64],0.4895412487027266
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,13455,55,1.04 [0.65-1.66],0.8649708402442923
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,11655,49,1.22 [0.94-1.59],0.1323627925678104
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,11703,50,1.42 [0.98-2.04],0.0630705188875396
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,13468,56,0.60 [0.39-0.93],0.0206047494118816
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",11639,49,0.98 [0.53-1.81],0.9526338130973836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,13210,53,1.32 [0.79-2.20],0.2889918110547301
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,13210,53,0.82 [0.54-1.27],0.3793677990091869
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,11468,50,1.59 [0.96-2.65],0.0728031385422761
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,11450,48,1.26 [0.90-1.76],0.1855355091715189
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,11296,47,0.83 [0.54-1.26],0.3765199176529981
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,11685,50,1.38 [1.02-1.86],0.0353341982173701
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,11703,50,1.15 [0.87-1.52],0.3429246797660452
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,13509,56,1.12 [0.89-1.41],0.3260046273465273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,11376,48,0.95 [0.66-1.39],0.8073832832933903
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,11376,48,0.78 [0.38-1.62],0.5044469179249078
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,13183,55,0.96 [0.53-1.73],0.889767360443527
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,11359,47,1.17 [0.80-1.70],0.41698192705712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,11359,47,1.95 [1.06-3.60],0.0321353748589215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,11376,48,1.04 [0.69-1.55],0.866246355517653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,13260,54,0.43 [0.20-0.95],0.0366025160180027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,11359,47,1.36 [0.94-1.96],0.1041193521434787
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,13524,56,1.14 [0.69-1.90],0.6089724177413738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,13455,55,1.32 [0.88-2.00],0.1801310994348314
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,13533,56,1.38 [0.66-2.86],0.3884611804519717
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,11376,48,0.79 [0.46-1.37],0.4020852924174881
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,13260,54,0.61 [0.31-1.20],0.1504298089495359
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,11605,50,1.42 [0.90-2.25],0.1338637609543211
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,13437,55,1.31 [0.80-2.14],0.2763745191996209
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,13437,55,0.78 [0.34-1.80],0.568580714482027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,11717,49,2.98 [1.10-8.09],0.0324999423643915
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,11721,50,1.47 [0.64-3.42],0.3662878529344726
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,11703,50,1.22 [0.83-1.79],0.3100365013468873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,11394,47,1.23 [0.94-1.62],0.1330742154686207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,11359,47,0.99 [0.70-1.40],0.9691411546876846
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,13183,55,1.02 [0.74-1.42],0.8871878353588294
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,11296,47,1.02 [0.46-2.28],0.9546943148117756
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,11655,49,1.28 [0.94-1.75],0.123100297791337
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,13210,53,0.75 [0.49-1.16],0.1958143457364683
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,13554,56,1.18 [0.85-1.64],0.3179559787198718
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,11359,47,1.21 [0.77-1.91],0.4045887033456627
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,11359,47,1.21 [0.53-2.80],0.6523649722097131
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,11359,47,1.01 [0.51-1.99],0.9856186054661644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,11296,47,1.86 [1.19-2.91],0.006226353555884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,11359,47,1.01 [0.66-1.56],0.9559463829676088
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",11359,47,1.09 [0.70-1.72],0.694238048230768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",13581,56,1.12 [0.90-1.38],0.3182082235068249
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",13183,55,1.15 [0.72-1.83],0.5599633615492912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,13210,53,1.32 [0.86-2.02],0.2013885226615203
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,13455,55,1.52 [0.71-3.23],0.2779415848404677
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,13154,55,1.22 [0.87-1.71],0.2469166709253657
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,11394,47,1.34 [0.93-1.93],0.1137436679066014
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,11359,47,0.88 [0.66-1.19],0.4200116769358477
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,11655,49,0.90 [0.34-2.40],0.8383005418508294
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",11728,48,2.95 [0.55-15.66],0.2044973941763346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,13183,55,1.19 [0.85-1.67],0.3035078377259277
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,11376,48,1.17 [0.97-1.42],0.1026148132072187
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,11703,50,1.09 [0.65-1.83],0.7456802037332215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,11685,50,1.20 [0.79-1.82],0.396912650231191
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,13509,56,1.16 [0.90-1.49],0.2428839036090575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,13533,56,0.76 [0.32-1.81],0.5345544606416409
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,11703,50,1.20 [0.76-1.88],0.4346725871175989
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,13084,51,1.03 [0.76-1.40],0.8341798479314815
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,11728,48,0.59 [0.19-1.78],0.3492764355273616
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,11359,47,0.76 [0.19-3.13],0.7073525255223467
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",11394,47,0.73 [0.34-1.55],0.4129626416284295
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",13581,56,1.09 [0.45-2.63],0.8435848950937821
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",13524,56,1.00 [0.38-2.67],0.996893788292572
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,11388,50,1.80 [0.90-3.59],0.0938338244426064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,13509,56,1.19 [0.87-1.63],0.2879335751760314
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,13415,54,0.80 [0.45-1.41],0.4336008543919911
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,11388,50,1.54 [0.98-2.39],0.0588747013737597
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,13293,54,0.79 [0.40-1.56],0.5001844828633384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,13210,53,1.23 [0.84-1.79],0.2935060946730459
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,13210,53,1.09 [0.49-2.44],0.8307547051797624
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,13509,56,1.09 [0.87-1.37],0.4457593911336218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,11685,50,0.86 [0.56-1.33],0.4960047187570463
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,11379,48,1.07 [0.80-1.43],0.6433445035752074
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,13164,55,1.10 [0.85-1.43],0.4746766065171721
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,13524,56,1.35 [0.50-3.65],0.5605539885756139
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,13437,55,2.11 [1.03-4.33],0.0406803134993709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",11721,50,2.04 [1.03-4.06],0.0416689283497632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",11376,48,0.87 [0.50-1.51],0.6235699575131153
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,11487,48,0.73 [0.28-1.93],0.5244690008166536
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,11655,49,0.79 [0.43-1.44],0.4431049544872443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,11685,50,1.32 [1.00-1.73],0.0470213937138835
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",13509,56,1.13 [0.67-1.92],0.6454017339989024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,11388,50,0.87 [0.53-1.42],0.5761268688664092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,11296,47,0.84 [0.51-1.38],0.4987738878737323
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,11639,49,1.22 [0.73-2.04],0.4455165442054504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,13509,56,1.09 [0.84-1.41],0.536398649460927
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,11700,50,1.21 [0.87-1.70],0.2592912705803082
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,11394,47,1.26 [0.83-1.93],0.2803602298012012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,11296,47,0.56 [0.26-1.17],0.121263181982933
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,11700,50,1.14 [0.85-1.55],0.3833049465214327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,13192,53,1.09 [0.89-1.33],0.3860134512248468
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,11376,48,1.15 [0.82-1.61],0.4167931717673979
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,11359,47,1.49 [0.53-4.15],0.4502558516816407
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,13509,56,1.19 [0.86-1.65],0.294490925305061
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,13524,56,1.03 [0.80-1.34],0.792135614110022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,13210,53,1.20 [0.82-1.74],0.3485714079537786
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,13685,57,0.99 [0.48-2.03],0.9727969997993784
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,11388,50,0.88 [0.41-1.89],0.7476523164848237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,11376,48,1.09 [0.78-1.54],0.604316636610338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,11685,50,1.62 [0.90-2.90],0.1059354347746018
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,13524,56,0.88 [0.61-1.26],0.4750495344900051
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,11450,48,1.37 [0.51-3.68],0.5305191178567885
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,13415,54,0.95 [0.56-1.62],0.8489085760192033
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,13265,53,1.28 [0.71-2.30],0.4148237087724123
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,11450,48,0.60 [0.17-2.10],0.4250086296227453
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,11721,50,1.87 [1.07-3.27],0.0287813009774249
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,11388,50,1.10 [0.61-1.97],0.7522185886097134
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,13293,54,0.65 [0.24-1.79],0.4032150117017776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,11376,48,1.23 [0.80-1.90],0.3411019381238623
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,11394,47,1.12 [0.68-1.84],0.6591305360370641
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,10990,46,1.04 [0.80-1.35],0.7735697548757337
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,13502,56,1.07 [0.74-1.57],0.7073013017711761
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,11702,50,1.21 [0.82-1.79],0.3256594615381129
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,11562,49,1.25 [0.96-1.62],0.0963781192340897
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,11468,50,0.85 [0.34-2.13],0.7279888190936338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,11376,48,1.28 [0.61-2.72],0.515649983349141
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,11359,47,0.95 [0.53-1.72],0.8747737286021349
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,11359,47,1.48 [0.75-2.94],0.2603162131240468
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,13183,55,1.45 [0.86-2.45],0.1588912026027871
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,11376,48,1.15 [0.67-1.97],0.6060349260309505
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,11703,50,1.69 [0.98-2.91],0.056988517663292
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BSG,Basigin,13653,57,1.33 [0.38-4.70],0.6601907122186128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BSND,Barttin,11296,47,1.86 [1.31-2.66],0.0006014364789297
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,13653,57,1.60 [0.81-3.17],0.1743983941494143
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,13653,57,0.57 [0.33-0.99],0.0474421634053766
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,13210,53,1.16 [0.86-1.57],0.3324985658313714
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,11728,48,1.36 [0.36-5.12],0.6527526286505488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,11296,47,1.14 [0.91-1.44],0.2537761873599092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,11619,49,0.82 [0.40-1.70],0.5912645610497846
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,13581,56,1.06 [0.40-2.75],0.9127150338093256
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,13509,56,0.77 [0.41-1.45],0.4185367722999046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,11296,47,1.19 [0.65-2.17],0.5648979596522996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,13183,55,0.92 [0.61-1.39],0.6993067454141138
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,11359,47,0.90 [0.37-2.21],0.8212467896465413
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,13606,57,0.66 [0.24-1.80],0.4180112654478347
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",11703,50,1.00 [0.67-1.48],0.9989426158121664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,11388,50,1.09 [0.60-1.99],0.7706459850836976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,13533,56,1.35 [0.80-2.28],0.266455321985887
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,11450,48,1.13 [0.54-2.36],0.7442963819698208
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,11703,50,1.04 [0.47-2.30],0.9277974631482384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,11425,48,0.70 [0.42-1.17],0.1754861366520083
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,11728,48,1.63 [0.61-4.37],0.3275047867006704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,11708,48,2.02 [0.48-8.52],0.3373585651240939
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,11728,48,1.42 [0.39-5.21],0.5943448181719021
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C2,Complement C2,13515,56,1.26 [0.44-3.67],0.6674039762462023
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,13154,55,1.27 [0.81-1.97],0.2937237255242315
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,11379,48,1.48 [1.12-1.96],0.0060021486815103
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C3,Complement C3,11128,45,1.44 [0.97-2.15],0.0729380821483951
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,13554,56,0.86 [0.48-1.52],0.5970285007112772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C5,Complement C5,11728,48,0.50 [0.08-3.26],0.4716582906749921
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,11456,47,1.64 [0.65-4.12],0.2921321864415928
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,11685,50,1.23 [0.51-2.95],0.6454398487577072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,11728,48,1.12 [0.46-2.71],0.8014799302551111
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,11717,49,1.25 [0.70-2.22],0.451047917504608
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,11655,49,0.76 [0.55-1.07],0.1164565031763799
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,13173,54,0.75 [0.51-1.10],0.1469205272397695
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,13210,53,0.80 [0.33-1.92],0.6106658826748469
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,13455,55,1.55 [0.82-2.94],0.1796766114799869
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,13362,54,1.14 [0.90-1.44],0.2917168720235958
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,13646,56,0.85 [0.42-1.71],0.6540376661941079
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,13482,56,0.83 [0.59-1.16],0.267209955859932
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,13660,57,0.73 [0.49-1.08],0.1201846265197534
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,13685,57,1.25 [0.46-3.40],0.6556032229699943
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",13293,54,0.88 [0.67-1.16],0.3632680305291368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,13485,56,1.10 [0.75-1.59],0.6328109779072661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,11468,50,1.19 [0.58-2.45],0.6350049716663103
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,11388,50,1.20 [0.48-3.00],0.7011297760846318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,13646,56,1.21 [0.71-2.05],0.4893708677835001
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,11379,48,1.26 [0.88-1.80],0.210938119725261
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,11376,48,0.91 [0.38-2.20],0.8334548164665211
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,11359,47,1.02 [0.65-1.59],0.946167338292184
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,11376,48,1.11 [0.71-1.71],0.6527598587294166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,11703,50,1.47 [1.08-2.01],0.0145673814585637
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,11421,48,1.25 [0.95-1.64],0.1158540811763658
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,11379,48,0.99 [0.54-1.83],0.9816240102199082
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,13455,55,1.34 [0.73-2.45],0.3496320993767849
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,13183,55,1.10 [0.50-2.42],0.8176501679922763
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,13408,55,1.24 [0.84-1.83],0.2890856966496831
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,11685,50,1.07 [0.55-2.09],0.8322512002308708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,13605,56,1.05 [0.84-1.32],0.648664701025117
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,11394,47,1.40 [0.99-1.96],0.0538338038333611
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,11359,47,1.33 [0.74-2.38],0.3403731768466347
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,13210,53,0.88 [0.50-1.54],0.6601106157204645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,11379,48,1.12 [0.70-1.80],0.6261364037596712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,11703,50,1.19 [0.93-1.50],0.16328393152141
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,13491,54,0.95 [0.29-3.09],0.9268239390254888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,13439,56,0.93 [0.62-1.38],0.7082544584497439
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,11639,49,0.93 [0.43-2.03],0.85954415522156
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,11685,50,1.04 [0.79-1.37],0.7868547599584116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,13183,55,0.73 [0.46-1.18],0.1985695591947906
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,11379,48,1.64 [0.94-2.87],0.0815569445675494
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,13183,55,0.92 [0.65-1.32],0.6677982520208613
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,13183,55,0.96 [0.69-1.33],0.8018392585521472
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,13509,56,1.15 [0.82-1.61],0.4198980749923735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,13685,57,1.07 [0.82-1.40],0.5977023446169984
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,11468,50,0.95 [0.80-1.13],0.5858206400009953
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,11685,50,1.39 [1.01-1.90],0.0412314264425757
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,13609,56,1.11 [0.77-1.59],0.5838633143044997
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,11388,50,1.35 [0.95-1.92],0.0984115608600095
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,11359,47,0.99 [0.56-1.72],0.9598309515790102
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CAT,Catalase,11530,48,0.70 [0.41-1.20],0.1978029345055714
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,13505,54,1.15 [0.81-1.63],0.4446908289727321
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,11376,48,1.00 [0.76-1.32],0.971942212934543
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,13646,56,1.23 [0.59-2.56],0.5838639485036228
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,11394,47,1.26 [0.77-2.05],0.3627973494700339
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,11359,47,0.88 [0.42-1.85],0.734639927327509
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,13437,55,1.03 [0.75-1.42],0.8474893817230709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,11685,50,0.97 [0.60-1.58],0.9135914919084444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,11639,49,1.42 [0.89-2.27],0.1427743054635019
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,11379,48,1.27 [0.49-3.26],0.6207586926738891
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,11703,50,0.84 [0.57-1.25],0.3984643109164961
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,13523,54,1.05 [0.51-2.20],0.8897594872968301
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,11394,47,1.29 [0.84-1.99],0.2475165166350654
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,13680,57,0.85 [0.46-1.55],0.5939107353574509
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,13659,57,0.80 [0.57-1.12],0.1989154820374854
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,13443,55,1.52 [0.91-2.52],0.1067687824629693
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,13685,57,1.16 [0.69-1.94],0.5746093918021832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,13685,57,0.84 [0.55-1.28],0.4193925095042015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,13493,55,0.79 [0.61-1.03],0.078684507785925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,13292,55,0.80 [0.55-1.16],0.2381555363731641
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,13653,57,0.98 [0.81-1.18],0.7943722192022299
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,13415,54,0.85 [0.54-1.36],0.5011270061454836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,13680,57,0.70 [0.50-0.98],0.0351563397422128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,13581,56,0.73 [0.39-1.36],0.3273095910211934
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,13369,55,0.99 [0.62-1.58],0.9768317234639616
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,13581,56,1.10 [0.62-1.95],0.7371276896629668
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,13560,56,0.88 [0.66-1.17],0.3926205331065834
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,13680,57,1.29 [0.82-2.05],0.2743047566753469
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,13509,56,0.83 [0.62-1.12],0.227652638281976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,13523,54,0.99 [0.67-1.47],0.957385026043774
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,13469,56,1.24 [0.86-1.79],0.2576523872995364
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,13509,56,1.08 [0.78-1.50],0.638040149314884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,13530,55,1.14 [0.83-1.55],0.4155010562969312
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,13533,56,1.06 [0.84-1.33],0.6092655727488195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,13509,56,0.85 [0.55-1.31],0.4608629388256017
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,13630,56,0.95 [0.65-1.40],0.8114934590404272
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,13436,55,0.93 [0.69-1.24],0.61423330387245
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,13524,56,0.91 [0.61-1.35],0.6393092722081226
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,13668,57,0.69 [0.33-1.46],0.3324537654415809
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,13646,56,1.01 [0.57-1.79],0.9715524938802697
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,13524,56,1.49 [0.84-2.66],0.1766740807643787
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,11468,50,1.00 [0.49-2.04],0.9968653108001072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,11388,50,0.91 [0.65-1.27],0.573443414245155
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,13437,55,0.90 [0.55-1.47],0.6694858634563612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,13210,53,1.03 [0.61-1.74],0.9158725081449202
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,11655,49,1.10 [0.57-2.12],0.7828376806073163
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,13524,56,1.22 [0.60-2.50],0.5798986537191542
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,13182,55,0.82 [0.46-1.46],0.494628381797234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,13680,57,1.18 [0.70-1.98],0.5281864727987584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,13533,56,0.93 [0.53-1.61],0.7832111100052718
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,13524,56,1.17 [0.50-2.73],0.7137805787100502
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,11379,48,1.35 [0.70-2.58],0.3709404597874093
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,13504,56,0.95 [0.80-1.14],0.5785105692987674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,13554,56,1.49 [0.53-4.19],0.4495179874646064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,11359,47,1.49 [0.92-2.43],0.1049876458278098
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,13509,56,2.88 [1.17-7.05],0.0210596194854517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,13472,56,1.54 [0.80-2.97],0.1968645956045961
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,13242,55,1.28 [0.68-2.39],0.4444671647309471
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,13541,56,0.50 [0.27-0.95],0.0331581022964837
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,13680,57,1.00 [0.55-1.81],0.9954871164057828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,11388,50,2.11 [1.13-3.93],0.019442881859056
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,13680,57,1.62 [0.70-3.73],0.2562121624055393
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,11700,50,0.98 [0.50-1.93],0.9502820220360396
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,13554,56,0.84 [0.44-1.57],0.5787925600699919
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,13437,55,1.11 [0.56-2.19],0.7732265313450658
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,13519,56,1.22 [0.62-2.38],0.5620480779853985
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,13210,53,0.90 [0.44-1.82],0.7620710319614108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,13523,54,1.09 [0.76-1.58],0.63818801243037
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,11450,48,1.12 [0.43-2.93],0.8152076699196567
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,13653,57,0.59 [0.29-1.19],0.1390146621549289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,13602,56,0.92 [0.49-1.72],0.7957577853820379
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,13646,56,1.08 [0.73-1.60],0.6917571291137738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,13524,56,1.15 [0.61-2.17],0.6598362033202219
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,13455,55,0.83 [0.36-1.94],0.6731053484800151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,13554,56,1.09 [0.81-1.48],0.571405895682772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,13595,57,1.54 [0.59-4.00],0.3731774457059388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,11388,50,1.75 [1.01-3.04],0.0451605931021065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,13455,55,0.85 [0.37-1.91],0.6850746874250815
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,11376,48,0.81 [0.34-1.94],0.6417128225662605
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,11468,50,0.98 [0.46-2.11],0.9636353781154668
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,11388,50,1.27 [1.05-1.53],0.0139825133233068
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,13485,56,1.12 [0.52-2.40],0.7705034945275016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,13509,55,1.25 [0.80-1.95],0.3347912499891811
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,13680,57,1.18 [0.87-1.59],0.2892769827895824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,13389,55,1.72 [0.88-3.36],0.1126741054787008
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,13560,56,0.49 [0.22-1.10],0.0851766837023322
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,13630,56,1.41 [0.69-2.89],0.3467525150582967
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,13010,52,0.93 [0.35-2.50],0.8845882239061232
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,13491,56,1.73 [0.45-6.64],0.4270017910696406
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,12998,54,0.84 [0.25-2.84],0.7747952878407555
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,11661,48,1.12 [0.62-2.02],0.7099386360485547
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,13653,57,0.90 [0.59-1.40],0.6510367174329692
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,13415,54,1.55 [0.98-2.46],0.0631903420413453
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,13451,53,1.04 [0.79-1.37],0.7677028290094532
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,11368,50,1.58 [0.89-2.80],0.1186664082726179
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,13509,56,1.21 [0.68-2.14],0.5228785017614311
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,11450,48,0.98 [0.50-1.94],0.9650332917154476
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,13653,57,0.82 [0.41-1.65],0.5832984463751301
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,13680,57,0.76 [0.42-1.36],0.3521300774888032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,11721,50,0.86 [0.38-1.96],0.7199349405709143
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,11468,50,1.18 [0.66-2.11],0.5843337365964718
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,13509,56,0.83 [0.40-1.73],0.6251062554486325
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,13509,56,2.30 [1.07-4.92],0.0324852386223442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,11655,49,1.14 [0.45-2.89],0.7855506723989771
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,13653,57,1.07 [0.66-1.74],0.7750471834038759
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,12969,55,0.87 [0.40-1.92],0.734921635962704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,13524,56,0.92 [0.27-3.19],0.9003333741743119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,13524,56,2.10 [0.81-5.47],0.1274995013441313
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,11700,50,0.84 [0.47-1.51],0.5650576445469904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,11685,50,1.21 [0.44-3.30],0.7109887638301564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,11296,47,0.91 [0.57-1.45],0.6959255539730773
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,11296,47,0.86 [0.42-1.79],0.6933519466648892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,11641,49,1.42 [0.99-2.03],0.05628236799843
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,13210,53,0.95 [0.63-1.43],0.8031924047816611
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,13554,56,1.18 [0.89-1.55],0.2414520299404991
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,11655,49,1.26 [0.98-1.62],0.0706747634210607
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,13437,55,0.88 [0.52-1.47],0.6183216835798913
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,13013,51,0.92 [0.48-1.75],0.8022398635093573
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,13624,57,0.96 [0.54-1.72],0.9032333903530958
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,13523,54,0.97 [0.68-1.39],0.8673215537289694
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,13523,54,0.95 [0.48-1.88],0.8863955862776335
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,11468,50,1.31 [0.58-2.92],0.5144172357319636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,11685,50,0.92 [0.33-2.58],0.8702722169376222
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,13653,57,1.56 [0.84-2.91],0.1619822709678332
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,11376,48,0.97 [0.54-1.74],0.926254533462398
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,13685,57,0.43 [0.19-0.98],0.0445159095303844
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,13523,54,1.04 [0.55-1.95],0.9063041404361758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,13183,55,1.23 [0.75-2.03],0.4151433251420886
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,13455,55,0.91 [0.67-1.24],0.5459482576032813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,13523,54,1.44 [0.76-2.75],0.2673502088555706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,11296,47,1.18 [0.56-2.49],0.6584314507253153
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,11703,50,1.54 [1.07-2.21],0.0195062263920266
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,11376,48,0.88 [0.50-1.54],0.6525023415669635
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,13455,55,0.97 [0.77-1.21],0.7579418027197218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,13455,55,1.18 [0.91-1.53],0.2252001072599016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,13455,55,1.34 [0.64-2.81],0.434913465760997
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,13544,56,0.73 [0.31-1.73],0.4730317805383615
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,13636,57,0.93 [0.54-1.60],0.7844679399360625
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,13531,55,1.35 [0.49-3.74],0.5615684640546192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,11655,49,1.05 [0.75-1.46],0.791692101441013
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,11468,50,0.85 [0.54-1.36],0.5050502325127969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,11655,49,1.26 [0.64-2.48],0.5055843625808678
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,11468,50,1.08 [0.61-1.92],0.7900757958148417
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,13509,56,1.06 [0.81-1.39],0.6554298824966552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,13210,53,1.25 [0.80-1.97],0.3249476629176268
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,13010,53,1.32 [0.91-1.90],0.1395564392042164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,11700,50,1.60 [0.86-2.94],0.1352851910104761
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,13293,54,1.29 [0.82-2.03],0.2695110920773091
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,11388,50,0.93 [0.45-1.92],0.8353951801412498
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,13293,54,0.90 [0.47-1.73],0.7529695509251824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,11700,50,0.90 [0.57-1.43],0.6639441352096652
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,13663,57,1.00 [0.65-1.54],0.9944516629466776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,11450,48,1.60 [0.61-4.19],0.3382903706359277
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,11388,50,1.67 [1.14-2.44],0.0086086897819182
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,11376,48,1.05 [0.68-1.63],0.8257028606012269
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,11468,50,0.83 [0.50-1.40],0.4916646994298361
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,11468,50,0.91 [0.61-1.36],0.6499279010615859
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,11359,47,1.22 [0.76-1.96],0.4165583790518812
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,11296,47,1.25 [0.74-2.10],0.4063256795607161
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,13260,54,0.74 [0.45-1.22],0.2387822263540951
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,11394,47,1.52 [1.12-2.06],0.0073941557103279
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,13210,53,1.10 [0.80-1.53],0.5600767255906035
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,11468,50,1.02 [0.62-1.68],0.9362418040388092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,11296,47,1.19 [0.60-2.36],0.6283263219104391
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,13185,54,1.08 [0.76-1.52],0.6827034317956477
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,13210,53,1.00 [0.68-1.47],0.9941702695808708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,13183,55,1.17 [0.80-1.72],0.4229508673448596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,13542,57,1.06 [0.79-1.43],0.6938935808511029
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,13455,55,1.30 [0.86-1.97],0.2101912984030905
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,13455,55,1.20 [0.88-1.64],0.2486352046964813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,13183,55,1.17 [0.83-1.64],0.3642128695252472
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,11655,49,1.40 [1.01-1.95],0.0432529090404868
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,11500,48,1.29 [0.57-2.95],0.5437326158849416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,13210,53,1.07 [0.65-1.77],0.7763144245733491
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,11728,48,1.67 [0.42-6.60],0.4644837137233379
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,11041,44,2.07 [0.61-6.94],0.2409229475706585
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,11647,48,1.23 [0.73-2.07],0.4260703648978849
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,11710,47,0.94 [0.65-1.37],0.7511118841204291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,11567,48,0.99 [0.51-1.92],0.9743889075813176
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,11728,48,1.03 [0.27-3.95],0.9614248931314582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CFP,Properdin,11728,48,0.80 [0.23-2.85],0.7329663959052645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,13524,56,1.08 [0.84-1.39],0.5314611782972518
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,11717,49,1.10 [0.69-1.77],0.6839730580521126
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,11379,48,1.15 [0.62-2.15],0.6520704212609771
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,13523,54,1.07 [0.60-1.90],0.8143193391974517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,13210,53,0.88 [0.58-1.32],0.5251623718223483
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,11450,48,1.03 [0.61-1.73],0.9243151924852931
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",11685,50,0.85 [0.41-1.76],0.6613760622444109
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,11639,49,1.28 [0.58-2.81],0.5469396601015605
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,13293,54,0.53 [0.25-1.09],0.0843522989482156
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,11700,50,1.11 [0.82-1.51],0.5056632166063644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,13596,57,1.81 [1.00-3.29],0.0518452591345107
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,13161,55,0.78 [0.54-1.12],0.1735137151961643
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,13567,55,1.13 [0.92-1.39],0.2515787149085435
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,13508,56,1.80 [0.95-3.42],0.0711925116512781
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,11379,48,1.56 [1.05-2.31],0.0259810278595729
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,13437,55,1.10 [0.81-1.50],0.5210297981343293
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,11721,50,1.37 [0.85-2.19],0.1969773296434526
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,11376,48,1.11 [0.80-1.54],0.5265584219037562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,13560,56,1.18 [0.54-2.57],0.683962423534521
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,13523,54,1.20 [0.83-1.75],0.3351051502646814
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,11379,48,1.67 [1.04-2.67],0.034287024568832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,13554,56,1.09 [0.76-1.57],0.6381195762127461
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,11700,50,0.93 [0.57-1.53],0.7842101122268007
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,11468,50,0.80 [0.40-1.58],0.5135815247820441
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,11655,49,1.37 [1.02-1.83],0.0342077420178055
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,11379,48,0.81 [0.43-1.53],0.5125137830617865
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,13602,56,0.65 [0.24-1.76],0.3984413787835854
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,11700,50,1.11 [0.71-1.74],0.6425789542759102
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",13456,55,0.94 [0.68-1.31],0.7334108948722491
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,11296,47,0.83 [0.53-1.29],0.4080316482081643
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,13505,54,0.72 [0.49-1.08],0.1122571452250492
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,13437,55,1.21 [0.62-2.35],0.5812347236888988
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,13495,56,0.80 [0.48-1.31],0.3667118107277498
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,11388,50,1.62 [0.47-5.56],0.446758588525475
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,13524,56,0.79 [0.36-1.72],0.5566325588563793
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,13293,54,0.94 [0.43-2.02],0.8676805384457611
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,13653,57,1.12 [0.88-1.42],0.3458909365079285
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,11379,48,1.03 [0.60-1.75],0.9255447049582236
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,11452,48,0.74 [0.20-2.74],0.6545471841143746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,13509,56,1.91 [0.94-3.87],0.0751207199989386
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,13509,56,0.82 [0.49-1.37],0.4465813021441688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,13509,56,1.01 [0.69-1.48],0.9621098990829048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,13509,56,1.37 [0.68-2.76],0.3800035875379707
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,11674,50,0.76 [0.43-1.34],0.3453901857849818
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,13472,53,2.24 [0.97-5.15],0.0582506241150645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,13210,53,1.35 [0.82-2.25],0.242093519689629
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,13680,57,1.06 [0.69-1.63],0.7927298620077068
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,11379,48,1.03 [0.55-1.92],0.9270310182819654
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,11379,48,0.57 [0.21-1.58],0.2800214770986081
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,11296,47,0.54 [0.26-1.12],0.0967774944555655
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,13509,56,1.10 [0.89-1.35],0.393772177296102
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,13646,56,2.28 [0.74-6.99],0.1506886162625218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,11379,48,1.16 [0.53-2.50],0.7141730988701824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",13408,55,1.19 [0.93-1.52],0.1690642849918772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,13503,56,1.04 [0.74-1.46],0.8333016219849121
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,13154,55,1.02 [0.53-1.99],0.9430424762404304
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,13183,55,0.95 [0.60-1.52],0.8368386388095603
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,13680,57,0.76 [0.40-1.41],0.3767391762979835
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,11685,50,1.20 [0.53-2.69],0.6661788837042876
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,13293,54,1.32 [0.84-2.06],0.22988144397601
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,11728,48,1.09 [0.54-2.19],0.8095905145775126
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,13507,54,1.48 [0.90-2.43],0.1235546175934744
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,11721,50,1.37 [1.03-1.83],0.0317167241307512
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,11639,49,1.22 [0.88-1.69],0.2244581799428239
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,13533,56,1.06 [0.63-1.78],0.8227178677876743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,11376,48,1.26 [0.87-1.83],0.2184080159553553
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",11370,47,1.17 [0.83-1.66],0.3695558808254955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,13293,54,1.46 [1.15-1.86],0.0020222064880386
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,13455,55,1.23 [0.90-1.68],0.195807462878655
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNST,Consortin,13523,54,1.06 [0.85-1.32],0.6269189588347234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,11376,48,0.88 [0.39-1.98],0.7637220249469345
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,13685,57,1.47 [0.63-3.47],0.3752667789057694
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,13646,56,1.07 [0.63-1.80],0.7991729582550506
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,13524,56,1.06 [0.55-2.08],0.8548403004067211
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,13524,56,1.58 [0.59-4.22],0.3596152572536228
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,13558,57,1.33 [0.70-2.51],0.3823213418441941
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,13509,56,1.31 [0.74-2.33],0.3510084089074292
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,11379,48,0.98 [0.74-1.30],0.8908419676936027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,11721,50,1.20 [0.69-2.08],0.5261972445044705
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,11700,50,1.74 [0.61-4.95],0.2987399864778234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,13567,56,0.97 [0.35-2.69],0.9489150525298298
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,13685,57,0.61 [0.34-1.11],0.1080068803973436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,11655,49,0.74 [0.49-1.11],0.1455415880769886
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,11379,48,0.96 [0.65-1.42],0.8489027155550661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,11394,47,1.07 [0.77-1.50],0.6929885748316253
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,11700,50,0.72 [0.23-2.31],0.5825436366893165
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,13523,54,0.80 [0.43-1.49],0.4893584067774491
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,11451,50,1.19 [0.70-2.02],0.5289315789108893
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,11450,48,0.66 [0.31-1.39],0.2711470675010144
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,13685,57,0.57 [0.27-1.22],0.1501111282201065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,13509,56,0.79 [0.45-1.38],0.407921278760308
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,11468,50,0.79 [0.41-1.54],0.4875010097286838
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,13519,56,0.83 [0.32-2.21],0.7141967595207305
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,11394,47,1.43 [0.94-2.18],0.0976458268739901
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,11639,49,1.52 [0.93-2.49],0.0955497114018079
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,13346,54,0.92 [0.45-1.88],0.820264594538207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,13142,52,0.98 [0.74-1.31],0.893132492567601
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',11359,47,1.59 [0.93-2.70],0.0888393551986766
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,13183,55,0.88 [0.51-1.53],0.6479392147469558
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",11394,47,0.92 [0.49-1.73],0.8022498944175535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,13227,51,1.06 [0.82-1.38],0.6567415124182479
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,11376,48,0.83 [0.37-1.84],0.6407875837217349
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",13455,55,1.31 [0.96-1.79],0.0917815323970813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,11721,50,1.66 [0.77-3.60],0.1979029384636176
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,13685,57,0.97 [0.64-1.46],0.8831772755808376
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,13600,57,1.25 [0.88-1.77],0.2114959215892644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,11210,47,1.59 [0.81-3.11],0.1733183365210832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,13685,57,1.04 [0.69-1.57],0.8491377458290531
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,11701,48,1.30 [0.40-4.29],0.6612630560763642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,13558,56,0.71 [0.41-1.21],0.2104428098677198
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,11296,47,0.90 [0.35-2.37],0.8387508896392109
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,13594,57,1.08 [0.56-2.09],0.8213943225868776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",11388,50,2.10 [1.00-4.41],0.0499129551485542
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,13653,57,0.98 [0.69-1.39],0.9113809822418072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,11680,50,0.88 [0.45-1.70],0.7028774118820289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,11359,47,1.58 [0.98-2.55],0.0626019806199041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,13627,56,1.26 [0.70-2.29],0.4398068642387671
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,13554,56,1.05 [0.74-1.47],0.7991380641852963
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,11721,50,1.43 [0.48-4.22],0.522111158548398
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,11665,48,1.17 [0.54-2.54],0.6917605093561945
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,13533,56,1.10 [0.66-1.84],0.7042769270358766
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,13210,53,1.04 [0.79-1.36],0.7853701956238927
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,13408,55,1.10 [0.81-1.50],0.5361274101416115
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,11296,47,1.30 [0.91-1.85],0.1437305462222357
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,11296,47,1.12 [0.40-3.09],0.8312132916346384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,13327,54,1.27 [0.67-2.41],0.4637153335550144
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,11450,48,1.65 [0.81-3.35],0.1699856554242754
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,13560,56,1.36 [0.88-2.08],0.1630281104568389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,13186,53,0.82 [0.62-1.10],0.1873408672102238
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,13519,56,0.72 [0.32-1.62],0.4274386870907523
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,13293,54,0.92 [0.62-1.37],0.6920086652481552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,13581,56,1.43 [0.45-4.48],0.5445797906724958
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,13437,55,0.91 [0.47-1.76],0.7785902250200198
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,13646,56,1.14 [0.77-1.70],0.5050058058732527
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,11602,48,2.29 [0.81-6.43],0.1161668352541671
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,13532,56,1.09 [0.87-1.36],0.4517838002672066
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,13581,56,0.81 [0.34-1.95],0.6387466529996165
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,13105,56,1.06 [0.74-1.53],0.7456597228930539
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,13685,57,1.13 [0.51-2.50],0.7678332286635415
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,13437,55,1.14 [0.70-1.86],0.5967816393212506
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,11379,48,1.27 [0.81-2.00],0.2971286204859146
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,13293,54,0.99 [0.79-1.24],0.9348377285732132
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,11721,50,1.48 [1.00-2.19],0.0491313752348344
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,11685,50,0.83 [0.45-1.53],0.5571260842519186
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,11685,50,1.02 [0.77-1.35],0.8883860821243961
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,11376,48,1.12 [0.81-1.54],0.5019491157520976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,11394,47,1.28 [0.94-1.73],0.1140261891046149
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,11359,47,1.15 [0.94-1.40],0.1760777639571498
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,13581,56,0.91 [0.37-2.24],0.844894762418089
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,11717,49,1.20 [0.60-2.39],0.6000852333554612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,11359,47,1.21 [0.59-2.47],0.6036785858856764
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,13437,55,1.12 [0.77-1.63],0.5510027178889904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,11388,50,1.13 [0.61-2.08],0.6982825807936405
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,13260,54,0.83 [0.50-1.37],0.4684208490047264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,11388,50,1.51 [0.74-3.07],0.2589779161036973
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,11717,49,1.07 [0.53-2.15],0.854063346571134
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,11388,50,1.11 [0.74-1.66],0.6220644445910763
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,11703,50,1.44 [0.82-2.53],0.2023036787660047
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,11700,50,1.04 [0.46-2.36],0.9213102382542993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,11376,48,1.37 [0.88-2.14],0.1682348586964179
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,11359,47,0.83 [0.59-1.17],0.298261814425472
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,10136,42,1.30 [0.98-1.72],0.0639357074568974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,13514,56,0.85 [0.35-2.07],0.7171033022052966
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,13299,55,1.20 [0.78-1.85],0.3948804834367919
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,13181,55,1.09 [0.65-1.81],0.7541267806653568
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,13530,55,0.94 [0.72-1.24],0.664127325603115
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,13326,56,1.22 [0.71-2.11],0.4651152989333577
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,11442,50,1.12 [0.68-1.85],0.6595553157679519
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,11544,47,0.94 [0.34-2.57],0.8984543613334937
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,13293,54,1.22 [0.93-1.59],0.1469768333626444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,11700,50,0.70 [0.26-1.91],0.4859077805776646
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,11700,50,0.95 [0.39-2.31],0.912570635757232
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,11376,48,1.08 [0.52-2.27],0.8342338268730016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,13524,56,1.12 [0.72-1.74],0.6158826636117444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,13518,55,1.12 [0.76-1.65],0.5657907371591189
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,11685,50,1.06 [0.70-1.60],0.7836094633891215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,13514,56,1.49 [0.98-2.27],0.0606120883349634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,13492,56,0.80 [0.46-1.42],0.4510138960347726
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,12557,50,0.78 [0.38-1.58],0.4871473250415318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,11450,48,1.15 [0.69-1.93],0.5932238123571387
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,13554,56,1.37 [0.77-2.42],0.2791048216975362
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,13254,54,1.34 [0.96-1.87],0.0804394218535112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,13523,54,1.04 [0.38-2.83],0.9440213320732472
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,13680,57,0.88 [0.40-1.91],0.7438782408212216
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,10680,45,1.95 [0.61-6.20],0.2582394491918127
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,13613,56,0.73 [0.42-1.28],0.2722046799186287
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,13475,56,1.43 [0.67-3.04],0.3508490935463659
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,11379,48,1.39 [0.79-2.44],0.2547220207390401
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,11591,49,0.96 [0.61-1.51],0.8578336673000304
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,13437,55,0.98 [0.48-1.99],0.9450628300519328
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,13509,56,1.10 [0.71-1.71],0.6739551640567801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,13480,55,0.98 [0.77-1.25],0.886954835219506
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,13581,56,0.71 [0.48-1.07],0.09851136976848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,13653,57,0.75 [0.54-1.03],0.0742205912389137
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,13260,54,0.84 [0.46-1.53],0.5611607328461051
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,13653,57,0.80 [0.53-1.23],0.3114162332416639
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,13260,54,0.89 [0.58-1.36],0.5835297567100959
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,13654,56,0.61 [0.22-1.71],0.3500121930563366
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,13680,57,0.71 [0.41-1.21],0.2101686937860205
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,13509,55,1.01 [0.79-1.30],0.9427526997896905
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,13474,52,0.89 [0.72-1.09],0.2595258714054211
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,13680,57,0.93 [0.69-1.26],0.6453893131253554
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,13411,55,1.00 [0.70-1.43],0.9964319848557036
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,13581,56,0.77 [0.52-1.14],0.1962039645673505
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,11296,47,0.72 [0.45-1.16],0.1763551164013962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,11506,49,1.29 [0.82-2.02],0.2693104504598128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",11359,47,1.01 [0.74-1.38],0.9507917966099068
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,11296,47,1.04 [0.73-1.49],0.8345028616481001
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,11700,50,1.80 [0.56-5.80],0.3246730040017362
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,11450,48,1.20 [0.87-1.67],0.2688219675820436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,13646,56,1.10 [0.89-1.36],0.3855446610098968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,13581,56,1.19 [0.74-1.91],0.4822600302034879
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,11388,50,0.87 [0.52-1.44],0.5807642593087408
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,11388,50,1.24 [0.83-1.87],0.2928610453739443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,13509,56,1.14 [0.92-1.41],0.2315624213992493
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",13408,55,1.09 [0.79-1.50],0.6162979518162905
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,11696,49,1.29 [0.94-1.77],0.1173421998336327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,13462,56,1.20 [0.90-1.59],0.2214160553181902
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,11388,50,1.56 [1.02-2.40],0.0399108238660923
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,13581,56,1.15 [0.89-1.48],0.2883915602534226
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",13554,56,0.91 [0.46-1.80],0.78791720535345
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,11379,48,2.21 [1.08-4.52],0.0294451311830263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,11296,47,0.96 [0.62-1.51],0.875612681851405
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,11296,47,0.98 [0.40-2.36],0.956054402271588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCN,Decorin,13293,54,1.81 [0.62-5.34],0.2801412356285738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,11450,48,1.26 [0.93-1.70],0.1325336074703832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,13646,56,1.01 [0.71-1.45],0.944255471864744
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,13455,55,1.18 [0.93-1.50],0.1782892904948066
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,13183,55,1.17 [0.86-1.58],0.3255448494317968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,13523,54,0.83 [0.38-1.77],0.6232598705498371
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,11376,48,1.18 [0.86-1.60],0.3006660394217639
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,11296,47,0.97 [0.68-1.38],0.864369292870619
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,13554,56,0.86 [0.54-1.36],0.5104226222759352
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,11359,47,1.52 [0.89-2.60],0.1255244422569838
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",13455,55,1.18 [0.71-1.96],0.5251712741411609
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,13505,54,1.03 [0.63-1.66],0.9150121032995064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,11703,50,1.36 [0.91-2.03],0.1306489195765873
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,11450,48,0.83 [0.59-1.19],0.3165689717685815
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,13653,57,1.98 [0.80-4.92],0.1385798636103187
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,11700,50,0.85 [0.44-1.66],0.6405334856464326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,11655,49,1.38 [0.93-2.05],0.1142744155059407
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,11379,48,1.23 [0.71-2.11],0.4638862758648779
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,11388,50,0.97 [0.28-3.40],0.959518827708704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,11388,50,1.24 [0.84-1.82],0.2772460742515884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,11379,48,0.89 [0.41-1.96],0.7762450001486452
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,13210,53,0.77 [0.48-1.23],0.2697733259072647
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",13509,56,1.25 [0.98-1.59],0.0728108077698082
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,13204,53,1.40 [0.94-2.08],0.0951763532145931
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,11303,49,1.10 [0.61-1.98],0.7541352243123676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,11376,48,0.89 [0.53-1.51],0.6715050562534435
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,11376,48,1.01 [0.71-1.42],0.9711279028138008
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,11376,48,1.00 [0.62-1.60],0.9841801738146038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,13325,55,0.85 [0.72-1.01],0.0651485159163595
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,11359,47,0.93 [0.52-1.64],0.7956787620955427
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,11388,50,1.37 [0.94-1.99],0.1022843005778816
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,13680,57,1.03 [0.73-1.44],0.8685313016640066
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,11376,48,1.35 [0.87-2.09],0.1770181884204374
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,11388,50,1.36 [0.85-2.18],0.204368325321243
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,13260,54,1.10 [0.57-2.14],0.7679354554048263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,11359,47,0.83 [0.43-1.58],0.5672835646783176
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,11639,49,0.79 [0.38-1.63],0.5236559633002893
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,11685,50,1.45 [0.97-2.17],0.073200268024504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",13472,53,1.07 [0.86-1.33],0.5581104437323393
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,11379,48,1.50 [0.91-2.47],0.1138256737832039
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,11450,48,0.79 [0.27-2.26],0.6555394606152727
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,13653,57,1.06 [0.72-1.56],0.7553074436328296
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,13685,57,1.29 [0.58-2.88],0.5272516047115419
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,13414,55,1.58 [1.00-2.50],0.0520442479060204
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,13455,55,0.94 [0.72-1.22],0.629818530244884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,11685,50,1.29 [0.91-1.83],0.1549213474426954
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,11703,50,0.75 [0.39-1.44],0.3870747231406384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,13685,57,1.08 [0.70-1.67],0.7209321563335636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,13554,56,1.21 [0.52-2.79],0.6579037281769737
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,11394,47,1.00 [0.71-1.41],0.9947403367880032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,11394,47,1.28 [0.82-1.99],0.2729982449571759
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,11394,47,1.27 [0.78-2.06],0.3400628615253746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,11296,47,0.91 [0.49-1.70],0.7682047133453628
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,13629,56,1.14 [0.86-1.52],0.36068288935352
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,11685,50,0.98 [0.68-1.41],0.9079264211206004
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,13455,55,1.06 [0.81-1.39],0.6892452540041976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,11655,49,1.31 [0.90-1.90],0.1581237167290034
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,11450,48,1.01 [0.61-1.66],0.9775345823944436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,11332,47,1.32 [0.95-1.83],0.0925461725045174
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,13293,54,1.07 [0.72-1.58],0.7520883458654415
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,11685,50,1.43 [0.77-2.66],0.2579800713995835
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,11394,47,1.25 [0.90-1.72],0.1784469904916094
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,11655,49,1.35 [0.96-1.90],0.0842108247269843
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,13497,55,3.20 [1.31-7.77],0.0103560105798223
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,11376,48,0.80 [0.55-1.16],0.2416979522984196
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,11655,49,1.39 [1.08-1.80],0.0114039921511895
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,11703,50,1.10 [0.69-1.75],0.6963791626373584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,13437,55,1.15 [0.81-1.64],0.4439702082231337
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,11685,50,0.91 [0.58-1.40],0.6602375654257324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,13553,56,0.80 [0.51-1.25],0.3248860403323261
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,11379,48,1.48 [0.87-2.54],0.1478392637464482
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,11376,48,0.89 [0.67-1.17],0.3905526292134917
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,11685,50,1.24 [1.00-1.54],0.0475367623826824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,13523,54,1.12 [0.93-1.37],0.2373270184745374
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,13408,55,1.36 [0.83-2.23],0.2267083229354182
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,13455,55,2.50 [1.18-5.30],0.017282705896542
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,13509,56,1.26 [0.64-2.47],0.4999163930947512
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,13213,55,1.01 [0.45-2.27],0.9746171450608296
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,13455,55,1.41 [0.68-2.90],0.3520415248668584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,13408,54,1.18 [0.79-1.77],0.418653770466546
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,13685,57,0.87 [0.37-2.02],0.7393705944551541
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,13606,56,0.96 [0.64-1.42],0.821955308815632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,13437,55,1.16 [0.67-2.03],0.5916308186556685
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,13455,55,1.18 [0.78-1.79],0.4243511199846389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,13374,55,0.85 [0.41-1.76],0.65328559364499
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,11703,50,1.85 [0.90-3.82],0.0955265965248098
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,13524,56,1.63 [0.68-3.91],0.2720483423323661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,13607,56,0.73 [0.36-1.50],0.3957022538615337
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,13401,55,1.07 [0.67-1.70],0.7766391186337839
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,11450,48,1.28 [0.93-1.74],0.1245096371104537
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,11625,49,1.78 [1.09-2.93],0.0223239192647609
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,11379,48,0.78 [0.49-1.26],0.3167632603333133
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,13455,55,0.98 [0.35-2.74],0.9731951260940775
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,11721,50,1.25 [0.85-1.82],0.2547721163343661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,13293,54,0.98 [0.70-1.37],0.8957247109737895
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,11639,49,0.92 [0.46-1.83],0.8021058502422463
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,11379,48,0.62 [0.35-1.09],0.0961790990655008
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,13183,55,0.87 [0.64-1.19],0.389461549621648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",11655,49,1.30 [1.01-1.69],0.0443248720725395
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,11685,50,1.40 [0.81-2.45],0.2302077520179397
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,11639,49,1.25 [0.81-1.94],0.3097177238843507
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,11379,48,1.41 [1.08-1.83],0.0117275789653399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,11639,49,1.76 [1.06-2.94],0.0296480237249319
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,13437,55,1.21 [0.94-1.55],0.1413834958974459
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,13625,56,0.79 [0.36-1.72],0.5480043437890629
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,13183,55,1.82 [1.01-3.26],0.044961916795467
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",11721,50,0.97 [0.67-1.39],0.8617268207171114
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",11394,47,1.25 [0.95-1.64],0.104389455540253
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,11359,47,1.32 [0.91-1.92],0.1438984973659076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,11383,47,0.97 [0.45-2.08],0.939567775299686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,11376,48,0.81 [0.42-1.53],0.5097902107761078
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,13646,56,1.28 [0.62-2.63],0.4987701383256886
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,13509,56,1.13 [0.88-1.45],0.3273073376842816
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,11639,49,1.41 [0.83-2.42],0.2067962978212874
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,11359,47,1.65 [1.01-2.68],0.0436221701837164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,11703,50,1.12 [0.80-1.57],0.5135017911050572
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,13293,54,0.77 [0.38-1.55],0.4703174320723035
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,11394,47,1.98 [0.79-4.94],0.143154575431585
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,11388,50,1.08 [0.62-1.87],0.7855925199568866
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,11721,50,1.21 [0.92-1.59],0.183319493896941
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,11655,49,1.88 [1.04-3.40],0.0374247587026582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,11468,50,1.61 [0.91-2.85],0.0990551594235309
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,13502,55,1.03 [0.46-2.29],0.9433245115283556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,11703,50,1.46 [0.75-2.82],0.2665728003540484
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,13501,56,1.16 [0.47-2.87],0.7542640436033524
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,13415,54,1.30 [0.54-3.15],0.5622806549328486
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,11379,48,1.04 [0.68-1.61],0.846016467861032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,13492,55,1.04 [0.83-1.31],0.7258312954405735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,13210,53,1.02 [0.56-1.85],0.9546917078535708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,11655,49,1.02 [0.43-2.42],0.9719629460087106
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,13685,57,0.49 [0.12-2.05],0.3267595654964422
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,13509,56,0.82 [0.50-1.33],0.4153769769559237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,11721,50,1.27 [0.90-1.79],0.1788644914945227
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,11394,47,1.29 [1.00-1.65],0.0474472607946547
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",11685,50,1.10 [0.69-1.74],0.69252552197662
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",11624,49,1.16 [0.92-1.48],0.2130844442293154
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,11359,47,1.30 [0.90-1.87],0.1590697755924565
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,11394,47,1.19 [0.64-2.21],0.5894038874339493
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,13437,55,1.21 [0.80-1.82],0.3712819406294287
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,11388,50,1.31 [0.98-1.76],0.070520607065374
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,13523,54,0.93 [0.64-1.35],0.7097627147738483
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,13680,57,1.10 [0.87-1.39],0.4200729117740381
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,11703,50,1.10 [0.75-1.61],0.6201396013844837
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,11359,47,1.05 [0.58-1.90],0.8790566950741001
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,13260,54,0.65 [0.28-1.55],0.3347440609446011
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,11703,50,1.33 [0.97-1.82],0.0786713520281862
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,11376,48,1.23 [0.96-1.58],0.0979067610200644
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELN,Elastin,11721,50,2.08 [0.97-4.44],0.0594212178255968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,13455,55,0.89 [0.55-1.44],0.6338110400900876
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,11359,47,1.17 [0.64-2.14],0.6052878951233813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,13260,54,0.80 [0.47-1.35],0.4058312066531201
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,10840,46,1.64 [1.05-2.57],0.0306587807205104
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,13685,57,1.15 [0.29-4.59],0.840586406300333
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,13501,57,1.23 [0.91-1.66],0.1771416434049216
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,13653,57,1.11 [0.79-1.57],0.5519374835682032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,11394,47,1.13 [0.71-1.81],0.6093984587924592
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,11639,49,1.16 [0.81-1.66],0.4216977130780217
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,11359,47,1.91 [1.04-3.50],0.0370123797068038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,11359,47,1.29 [0.83-2.00],0.2569169833283331
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,13685,57,1.09 [0.50-2.40],0.8277756013020446
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,13581,56,1.21 [0.66-2.23],0.5384404905041992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,11394,47,1.55 [0.72-3.35],0.2596271172852329
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,13127,52,0.81 [0.62-1.07],0.1423890227338515
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,11639,49,1.42 [0.94-2.16],0.0986558135358357
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,13210,53,0.96 [0.54-1.70],0.8952418602940274
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,13293,54,1.40 [0.44-4.49],0.5729108521038816
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,13293,54,0.82 [0.35-1.94],0.649514378752001
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,11394,47,1.08 [0.68-1.72],0.7451523749309904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,11388,50,1.45 [0.66-3.18],0.3493876564030894
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,11379,48,1.24 [0.90-1.72],0.1859015439967728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,13522,56,0.98 [0.77-1.25],0.8849519308200515
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,11639,49,1.40 [1.01-1.93],0.0416736115333435
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,13553,56,1.22 [0.61-2.45],0.5743716179480303
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,13183,55,0.94 [0.63-1.39],0.7520130118215922
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,13041,54,0.82 [0.34-1.95],0.6520531009692712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,11450,48,1.73 [0.65-4.64],0.2734841909903097
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,13685,57,0.96 [0.35-2.60],0.9308597126000132
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,13408,55,1.75 [0.80-3.86],0.163688822686126
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,13293,54,0.95 [0.64-1.42],0.8111460620672917
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,11468,50,1.44 [0.96-2.14],0.0743284734565198
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,13509,56,1.06 [0.81-1.40],0.6579181991847283
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,11394,47,1.17 [0.83-1.65],0.3778323592584988
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,13627,56,0.55 [0.24-1.25],0.1548799533230344
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,13554,56,1.71 [0.65-4.47],0.2772025588418894
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,13465,55,0.87 [0.25-3.04],0.8315763224080297
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,13554,56,2.82 [1.06-7.47],0.036966886677293
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,13455,55,1.16 [0.92-1.46],0.2140351233538901
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,11379,48,1.08 [0.78-1.50],0.6374431418694826
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,11296,47,1.44 [0.98-2.12],0.0636150616793486
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,13408,55,1.16 [0.88-1.54],0.293294865637428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,11468,50,1.19 [0.56-2.50],0.6530560907345773
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,11388,50,1.26 [0.70-2.26],0.4437212748421562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,11639,49,0.84 [0.41-1.74],0.6389488803278898
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,11450,48,1.24 [0.98-1.58],0.0693047293716474
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,13436,55,1.95 [0.79-4.82],0.1462000116246942
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,11359,47,1.08 [0.63-1.84],0.7783106617805807
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,13685,57,1.32 [0.64-2.75],0.4497490225580229
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,13519,56,1.25 [0.63-2.48],0.5321205475454653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,11296,47,0.94 [0.56-1.60],0.8259969200156172
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,11388,50,1.25 [0.89-1.78],0.2021583313406955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,11685,50,1.39 [1.03-1.88],0.0305921620286891
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,11296,47,0.69 [0.30-1.59],0.3809994352341553
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,11388,50,1.26 [0.95-1.69],0.1119680856510443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,11468,50,1.36 [0.65-2.83],0.4154658855858343
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,11359,47,1.38 [1.03-1.85],0.0312464537668141
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,11359,47,1.19 [0.73-1.95],0.477537253057776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,13653,57,0.76 [0.28-2.04],0.5851388470867203
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,11717,49,0.94 [0.32-2.74],0.9127534587175552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,11556,46,1.24 [0.62-2.48],0.542288652024238
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,13524,56,1.22 [0.82-1.81],0.3361655005975443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,11728,48,1.21 [0.62-2.36],0.5682821795016925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,11661,48,0.87 [0.30-2.54],0.7953431499478882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,11728,48,4.69 [0.73-30.18],0.1039656797077524
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,13560,56,1.26 [0.85-1.86],0.2591634477202129
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,13560,56,1.31 [0.57-3.00],0.5250266877895979
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,13513,56,1.62 [0.74-3.54],0.2292998456336249
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,13515,56,0.70 [0.19-2.53],0.5818573895607171
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",13519,56,1.00 [0.77-1.28],0.969717937297522
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",13523,54,0.99 [0.72-1.35],0.9324779209125093
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",11721,50,0.95 [0.53-1.71],0.86867167259075
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",13685,57,0.84 [0.51-1.38],0.4918696955699068
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,13617,57,1.02 [0.73-1.42],0.9041115749112134
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,13276,54,0.95 [0.60-1.50],0.8371498876067558
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,13509,56,1.06 [0.70-1.60],0.7894111514248805
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,13523,54,1.19 [0.88-1.62],0.2581217112581968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,11655,49,1.40 [0.97-2.02],0.0753675422509018
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,11703,50,0.98 [0.82-1.16],0.7916954861888204
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,11639,49,1.39 [0.62-3.12],0.4210878774828972
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,11394,47,1.72 [1.13-2.62],0.0118479620022863
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,11721,50,1.18 [0.47-2.98],0.7283796024573026
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,13455,55,0.88 [0.46-1.67],0.6918001279303643
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,13505,54,0.81 [0.35-1.89],0.6329903602347765
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,11655,49,0.75 [0.53-1.05],0.0948880955053857
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,13685,57,0.48 [0.21-1.12],0.0908468168332897
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,11379,48,1.13 [0.78-1.63],0.5300209734546713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,13634,56,0.44 [0.17-1.09],0.0770253064083274
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,13680,57,1.01 [0.53-1.89],0.9871313013203976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,11700,50,2.13 [0.91-5.00],0.0826799629693216
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,11379,48,1.10 [0.71-1.70],0.6615152766226713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",13523,54,0.99 [0.71-1.38],0.9516035197080328
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,11721,50,0.66 [0.45-0.98],0.0387094140748194
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,13509,56,0.95 [0.57-1.57],0.8309822396462723
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,11703,50,2.56 [1.02-6.39],0.044822787427913
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,13524,56,1.13 [0.68-1.88],0.6445175559405255
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,13427,55,1.16 [0.75-1.80],0.5007736996029563
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,13210,53,1.08 [0.71-1.64],0.7168533481015504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,13489,56,1.01 [0.63-1.62],0.9522501885676334
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,11696,49,1.73 [1.00-3.01],0.0511530123266019
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,13427,56,1.32 [0.73-2.41],0.3614614649352179
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,13523,54,0.99 [0.57-1.71],0.9582519468684976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,13617,57,0.53 [0.31-0.91],0.0207030114619953
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,13260,54,0.47 [0.30-0.74],0.0011301873812718
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,13524,56,0.87 [0.56-1.34],0.5195324656251994
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,13509,56,0.83 [0.58-1.17],0.2866612786737006
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,13210,53,0.72 [0.45-1.16],0.1756523922946322
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",11359,47,0.71 [0.41-1.21],0.203179383634774
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",11359,47,1.47 [1.05-2.05],0.0249786425699004
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,13210,53,0.75 [0.47-1.20],0.2346104307814503
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,13210,53,0.87 [0.51-1.50],0.6255010509131136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,13515,56,0.83 [0.44-1.58],0.5717768342459153
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,11445,47,0.67 [0.26-1.68],0.3896618073060579
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",11703,50,1.41 [1.02-1.95],0.0372686045670439
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,11388,50,0.91 [0.48-1.74],0.7839521690045925
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,11388,50,0.93 [0.51-1.67],0.7992540514889777
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,13581,56,1.08 [0.79-1.46],0.6444762287089598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,13509,56,1.28 [0.91-1.79],0.1496546616698184
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,11388,50,0.84 [0.42-1.67],0.621911019874214
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,13625,56,0.97 [0.79-1.17],0.7235911985700081
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,13626,55,0.96 [0.66-1.39],0.829319108460746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,11388,50,1.75 [1.11-2.75],0.015679676192192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,13260,54,0.55 [0.26-1.19],0.1304281490057325
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,11388,50,1.11 [0.66-1.88],0.6916443917000457
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,11296,47,0.81 [0.53-1.24],0.3391086929711506
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,11273,47,1.36 [0.68-2.72],0.3836518485255382
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,13554,56,1.20 [0.56-2.57],0.6367848355931601
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,11700,50,0.84 [0.49-1.45],0.5390845247443072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,11685,50,1.61 [0.79-3.29],0.1872203965415314
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,13554,56,1.17 [0.38-3.59],0.777911662985348
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,11450,48,1.10 [0.67-1.83],0.6994515963865191
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,11717,49,1.05 [0.68-1.62],0.8321422151359801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,13183,55,0.89 [0.57-1.39],0.6123354843380813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",11376,48,0.86 [0.59-1.26],0.435208063034993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,11359,47,1.34 [0.88-2.05],0.1733899822263637
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,13183,55,1.23 [0.89-1.69],0.2062660820941615
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,13502,55,1.11 [0.82-1.49],0.49910846402165
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,11703,50,1.26 [0.96-1.65],0.0920632104904276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,13569,57,1.10 [0.89-1.35],0.3805343507303577
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,13437,55,1.21 [0.72-2.06],0.4726707558713307
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,13437,55,1.19 [0.92-1.54],0.1748445642331714
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,13154,55,1.34 [0.90-1.99],0.1460738422884758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,11655,49,1.25 [0.80-1.95],0.3206879544305085
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,13210,53,1.08 [0.87-1.35],0.4849670897411428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,13437,55,1.12 [0.48-2.61],0.7956640367846596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,13427,55,1.56 [0.74-3.30],0.2411132269083231
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,13210,53,0.63 [0.26-1.49],0.2920768200120612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,13680,57,0.45 [0.22-0.93],0.0322106117297677
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,13554,56,1.33 [0.66-2.72],0.4266360152619373
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,13183,55,0.97 [0.66-1.43],0.8771803613678489
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,13210,53,1.09 [0.54-2.17],0.8161650018523675
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,11728,48,1.27 [0.45-3.55],0.6547304787699246
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,11685,50,1.03 [0.57-1.85],0.9282455662499238
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,11639,49,1.82 [1.09-3.02],0.0210131041996409
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,11388,50,0.96 [0.74-1.25],0.7874652387588676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,13484,56,2.27 [1.02-5.07],0.0453806463681376
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,13653,57,1.23 [0.56-2.73],0.6064247700282112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,13509,55,0.90 [0.77-1.05],0.1755310715327783
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,11273,47,1.71 [0.80-3.69],0.1690782634148828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,13183,55,0.83 [0.43-1.63],0.5942620178709832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,11388,50,1.46 [0.91-2.35],0.1184528522205412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,13509,56,1.03 [0.78-1.35],0.8520140252444972
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,13210,53,0.93 [0.72-1.21],0.5864272292443535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,11359,47,1.33 [0.94-1.89],0.1036048167519581
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,11379,48,1.31 [0.66-2.60],0.4327386487044828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,13391,54,1.33 [0.54-3.26],0.5320447790443228
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,11394,47,0.93 [0.62-1.38],0.7085198772810122
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FST,Follistatin,13560,56,0.98 [0.63-1.53],0.9285388587451552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,11394,47,2.18 [0.68-7.01],0.1909029997913591
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,13497,55,0.99 [0.44-2.23],0.9756787012908266
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,11671,50,0.94 [0.68-1.31],0.726314114211801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,13599,57,0.85 [0.65-1.10],0.2151868505829914
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,11450,48,1.10 [0.71-1.69],0.6705793430749827
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FURIN,Furin,13554,56,1.23 [0.62-2.44],0.5587996644230084
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,13190,52,0.86 [0.45-1.63],0.6418256053106528
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",11446,50,0.95 [0.61-1.45],0.7971057392423609
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,13653,57,0.96 [0.57-1.62],0.8705136029563846
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",13437,55,1.46 [0.99-2.15],0.0567905874443593
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",13646,56,1.24 [0.91-1.69],0.1811816681177919
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,13260,54,1.13 [0.79-1.60],0.5069534136580544
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,13503,56,1.11 [0.86-1.44],0.4260802460860321
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,11379,48,1.14 [0.77-1.69],0.5047201701115078
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,11376,48,1.02 [0.54-1.92],0.9505152504239832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,11639,49,1.49 [0.99-2.23],0.0534331667587454
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,11468,50,1.13 [0.78-1.61],0.5220876524625042
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,11376,48,1.13 [0.78-1.63],0.5117775925365996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,11296,47,0.91 [0.31-2.68],0.8695124427140487
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,11388,50,0.74 [0.37-1.49],0.4059716788768549
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,11468,50,0.83 [0.43-1.59],0.5657002762881265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,11394,47,1.49 [0.94-2.36],0.0902254849088326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,11296,47,0.82 [0.49-1.38],0.4571949229414431
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,13581,56,1.14 [0.79-1.65],0.4830326339476588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,13455,55,1.22 [0.54-2.79],0.6323413766516299
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,13646,56,0.94 [0.37-2.39],0.900339769195382
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,13260,54,1.00 [0.56-1.80],0.9879013600761728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,11721,50,3.33 [1.24-8.97],0.0172850843542832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,13455,55,2.16 [0.74-6.32],0.1615925275116752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,11359,47,1.18 [0.61-2.26],0.624304672676041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,11197,47,2.08 [0.79-5.47],0.1353405635446312
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,11703,50,0.59 [0.18-1.89],0.3721038200013314
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,11468,50,1.29 [0.89-1.87],0.1804628767453477
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,13585,56,0.93 [0.38-2.31],0.8813653592251239
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,11359,47,2.03 [1.12-3.67],0.0191567928075417
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,11685,50,0.97 [0.77-1.23],0.7903613315741841
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,11296,47,2.44 [0.92-6.42],0.0721555455001688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",11394,47,1.26 [0.90-1.75],0.1803098919369346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,11379,48,1.14 [0.71-1.83],0.5858205214326782
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,11662,50,0.65 [0.47-0.92],0.0131793529456044
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,13260,54,1.15 [0.79-1.69],0.4689381722343275
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,13183,55,1.04 [0.64-1.68],0.8811214892577012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,11359,47,1.00 [0.54-1.84],0.9877866443175882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,11728,48,0.78 [0.27-2.24],0.6450080191194476
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,11685,50,1.28 [1.00-1.66],0.0534182723882812
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,13210,53,1.06 [0.87-1.29],0.5843362796044922
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,11160,47,1.10 [0.67-1.82],0.705901456492579
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,11359,47,0.91 [0.48-1.71],0.7623851947018327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",13455,55,1.20 [0.61-2.37],0.6032453681770061
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,13685,57,1.15 [0.68-1.95],0.6043174863520195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,13523,54,1.30 [0.67-2.54],0.4364239571582275
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,13183,55,1.02 [0.54-1.91],0.9602059670852066
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,11721,50,0.93 [0.57-1.52],0.7799409270442422
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,13194,53,0.95 [0.54-1.67],0.8711186727043175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,13210,53,1.08 [0.75-1.58],0.6728648368640968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,13210,53,0.95 [0.77-1.16],0.6022623387665029
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,13625,56,1.28 [0.54-3.04],0.5780679516631497
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,13455,55,2.35 [0.88-6.28],0.086994243400901
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,13395,55,1.92 [0.86-4.30],0.1105747757026558
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,11337,50,0.93 [0.60-1.46],0.7559401119148754
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,13183,55,1.36 [1.07-1.74],0.0127495628368549
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,11721,50,1.35 [0.94-1.94],0.1034105869672298
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,11700,50,1.28 [0.75-2.17],0.3706113105915337
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,13241,54,1.28 [0.66-2.50],0.4622500730672781
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,13501,56,0.83 [0.49-1.41],0.4919365819070215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,13437,55,1.30 [0.47-3.57],0.6143287214435811
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,13505,54,0.95 [0.83-1.09],0.4738978403600097
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,13210,53,0.86 [0.72-1.02],0.0876128092620346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,11450,48,1.09 [0.42-2.80],0.8658015460774449
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,13183,55,1.22 [0.89-1.66],0.2119386664281194
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,13523,54,1.13 [0.82-1.55],0.45293967311726
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,11703,50,1.55 [0.93-2.58],0.0957856658384385
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,11703,50,1.23 [0.89-1.70],0.2013270690180997
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,11450,48,0.81 [0.33-1.98],0.6375232138200575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,11296,47,1.06 [0.63-1.78],0.8181848423390939
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,11394,47,0.77 [0.40-1.47],0.4259035825926837
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,11685,50,0.80 [0.31-2.08],0.6541485442500723
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,11655,49,1.32 [0.99-1.77],0.061811491663282
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,11388,50,1.02 [0.57-1.81],0.9499434101784264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,11388,50,1.26 [0.95-1.67],0.1044593293228833
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,11296,47,1.15 [0.79-1.68],0.4704284155252364
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,12924,54,1.68 [0.75-3.77],0.2072126358004021
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,11421,48,1.26 [0.61-2.60],0.5376079950745396
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,13437,55,1.73 [1.01-2.97],0.046743593136453
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,11388,50,1.12 [0.54-2.34],0.7631140602006031
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,13293,54,0.82 [0.54-1.24],0.3448784467393143
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,13481,55,0.99 [0.52-1.87],0.9660786810059454
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,11376,48,1.35 [0.79-2.33],0.2764236441662899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,13446,54,0.73 [0.47-1.12],0.1459060736359316
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",11450,48,1.30 [0.96-1.75],0.0863295587099155
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,13183,55,1.00 [0.61-1.62],0.98522504441858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,11639,49,1.49 [1.11-2.00],0.0077241726307203
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,11434,48,1.07 [0.53-2.16],0.8482884143525012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,11721,50,1.46 [1.01-2.12],0.0463895096515345
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,13680,57,1.09 [0.69-1.72],0.7151058541567564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,11450,48,1.27 [0.85-1.89],0.2496244031905036
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,11703,50,1.01 [0.75-1.34],0.9653793611848864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,13210,53,1.09 [0.76-1.56],0.6545952085563962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,11379,48,1.28 [0.89-1.84],0.1753601494286318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,13524,56,0.85 [0.54-1.35],0.4997875162861751
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,11394,47,1.39 [0.76-2.54],0.2789630760131438
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,11450,48,1.13 [0.54-2.39],0.7424385561437405
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,11703,50,1.31 [0.96-1.80],0.0913722790768169
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,13653,57,0.65 [0.22-1.87],0.419028737307105
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,13509,56,1.09 [0.86-1.38],0.4895866820031025
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,11655,49,1.55 [0.90-2.66],0.116297017498389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",11700,50,1.14 [0.60-2.15],0.6941339564109442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,13433,56,1.66 [0.82-3.35],0.1618139130984091
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,11359,47,1.19 [0.79-1.80],0.4137626884389509
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,13117,51,1.09 [0.82-1.45],0.5371300041080208
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,11450,48,2.13 [0.94-4.85],0.0706914322796323
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,13503,56,1.11 [0.85-1.45],0.448467057950728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,13455,55,0.96 [0.80-1.15],0.6513539128238064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,13646,56,0.72 [0.32-1.60],0.4160980174599821
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,13437,55,1.04 [0.68-1.59],0.8567628823578702
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,11639,49,1.01 [0.59-1.71],0.9742410838358913
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,11655,49,0.97 [0.56-1.68],0.920675226408158
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,11717,49,1.54 [0.92-2.57],0.1020218329029735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,11655,49,1.14 [0.76-1.70],0.5287191552976898
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,13183,55,0.46 [0.16-1.31],0.1458942128360998
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,13163,53,0.88 [0.37-2.07],0.7633368190379329
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,11376,48,1.06 [0.71-1.56],0.7858414690141003
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,11703,50,1.53 [0.93-2.52],0.0941667942151076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,11655,49,0.66 [0.44-0.99],0.0439307910761558
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,13293,54,1.16 [0.80-1.69],0.4205821000739423
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,11639,49,1.38 [0.98-1.96],0.0683067840565191
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,13523,54,1.13 [0.93-1.36],0.2260357979068363
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,11721,50,1.37 [0.92-2.06],0.1224512217477649
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",11703,50,1.38 [0.81-2.36],0.2414449511193154
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",11376,48,1.14 [0.76-1.70],0.5325402955017955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,13293,54,1.19 [0.80-1.77],0.3899862066815626
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,13461,56,0.51 [0.19-1.38],0.1865328758616086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,11394,47,1.03 [0.60-1.75],0.9205151182753272
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",13455,55,1.23 [0.85-1.76],0.2685164665165488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,11236,47,1.36 [1.00-1.85],0.0495837829739434
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,13210,53,1.08 [0.85-1.38],0.5396010200095555
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,11672,48,4.13 [0.86-19.86],0.0767711411101803
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",11642,48,1.10 [0.31-3.90],0.8877320820875099
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,13505,54,0.91 [0.68-1.22],0.5302498105308309
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,13210,53,0.84 [0.59-1.19],0.3233761049053554
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,11359,47,0.93 [0.61-1.41],0.7339450663743832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,13101,55,1.36 [1.01-1.81],0.0397247976211984
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,11685,50,1.06 [0.94-1.19],0.3337335823215326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,11468,50,0.63 [0.35-1.12],0.1155297401008639
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,11379,48,1.38 [0.99-1.93],0.0596182571948094
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,13459,55,0.80 [0.38-1.68],0.5479461288313188
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,11468,50,0.84 [0.58-1.21],0.3384877662791545
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,11359,47,1.32 [0.82-2.11],0.251335592895553
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,13570,56,0.91 [0.60-1.36],0.6376368729991582
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",13293,54,1.13 [0.88-1.46],0.341940063532426
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,13680,57,0.87 [0.44-1.73],0.6959854126723402
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,13509,56,1.22 [0.89-1.66],0.2116554901527416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,13293,54,0.80 [0.55-1.15],0.221371872906258
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,11296,47,1.05 [0.61-1.82],0.8493072210782003
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",11359,47,0.67 [0.37-1.24],0.2075610094730084
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",13609,56,0.88 [0.64-1.21],0.426516108568895
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,13646,56,1.02 [0.85-1.21],0.8464267244444421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",13524,56,1.15 [0.85-1.56],0.367580091462133
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,13630,56,1.09 [0.73-1.62],0.6886917581824084
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,13524,56,0.91 [0.45-1.85],0.7985460539407624
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,13609,56,1.03 [0.75-1.41],0.8702215072502679
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,13646,56,0.79 [0.53-1.18],0.2542772961894352
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,11721,50,0.88 [0.68-1.15],0.3484393678626453
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,11359,47,1.35 [1.00-1.82],0.0494343362220616
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,13680,57,1.09 [0.72-1.65],0.6843996336527511
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,11388,50,1.02 [0.68-1.55],0.9132113665540263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,11376,48,0.86 [0.52-1.41],0.5507640012252346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,11655,49,0.75 [0.40-1.42],0.3818506877510769
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,13630,56,0.94 [0.73-1.20],0.6205608866189146
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,11685,50,1.20 [0.81-1.77],0.3602362258817462
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,13293,54,0.72 [0.43-1.19],0.1956681156799913
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,11450,48,1.01 [0.36-2.87],0.9778031247378736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,11685,50,1.19 [0.62-2.28],0.6115405177780576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,11721,50,1.16 [0.40-3.34],0.7823192884443191
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,13509,56,1.11 [0.84-1.47],0.4732573330126152
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,13680,57,1.12 [0.57-2.21],0.7501269848841221
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,11604,48,1.20 [0.45-3.19],0.712049959693468
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,13210,53,1.15 [0.85-1.55],0.375862659698461
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,11685,50,1.30 [0.92-1.83],0.1363229600616998
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,11388,50,0.87 [0.55-1.36],0.5397495397835275
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,11359,47,0.85 [0.36-1.99],0.7017394518382075
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,11669,50,1.10 [0.62-1.94],0.7551266430985694
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,11703,50,0.80 [0.42-1.53],0.5027211719443246
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,13293,54,0.61 [0.25-1.47],0.2711484983203286
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",11703,50,1.40 [0.61-3.24],0.4253078385635533
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",13466,56,0.90 [0.46-1.74],0.744674937468655
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",13509,56,0.54 [0.22-1.35],0.1901061464201557
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,13646,56,0.61 [0.37-0.99],0.0458201988299734
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,11426,47,1.05 [0.64-1.71],0.857913473258384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",11394,47,1.46 [0.90-2.35],0.1216327912574712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",11359,47,1.38 [0.85-2.24],0.1940962469779719
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,11282,47,0.78 [0.40-1.52],0.4580718345724718
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,13373,53,0.73 [0.42-1.25],0.2448246220149003
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,13183,55,1.15 [0.71-1.85],0.5650723767998892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,11379,48,1.01 [0.69-1.48],0.94714472195526
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,13364,54,0.68 [0.40-1.14],0.1402225487621429
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,13249,54,1.07 [0.79-1.45],0.6639046711263556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,11703,50,1.27 [0.80-2.02],0.3174305655936981
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,13680,57,1.13 [0.82-1.56],0.4591646454943504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,13210,53,0.64 [0.33-1.25],0.1925976674086706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,11532,49,1.15 [0.86-1.54],0.3406577220928409
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,11452,50,1.05 [0.82-1.35],0.6792924726868725
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,11394,47,1.60 [0.90-2.84],0.1079688509478942
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,11661,48,0.79 [0.33-1.87],0.5902449293425869
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,11394,47,1.33 [0.98-1.80],0.069637040128201
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,13455,55,0.97 [0.52-1.80],0.9235685968622058
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,13646,56,0.67 [0.33-1.36],0.270843715893758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,11388,50,2.03 [0.91-4.50],0.0825312508561736
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,11394,47,1.11 [0.84-1.48],0.4694871370695119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,13509,56,1.22 [0.67-2.24],0.5168033338854523
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,11685,50,1.28 [0.85-1.95],0.2398179565118947
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,11359,47,1.54 [1.04-2.26],0.0292516321169153
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,11394,47,1.56 [0.92-2.65],0.0967506978474024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,13122,55,0.83 [0.55-1.26],0.3852563441506196
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,13553,56,1.17 [0.86-1.60],0.3145512551451189
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,11639,49,1.21 [0.56-2.61],0.6199116316093967
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,13289,52,1.02 [0.71-1.46],0.9307119893041012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,13646,56,0.59 [0.29-1.19],0.1388861688636389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,13373,55,1.09 [0.40-2.96],0.8644949438256674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,11376,48,0.89 [0.60-1.32],0.5555222526918393
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,11376,48,0.87 [0.44-1.73],0.6848102854830022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",13554,56,1.24 [0.85-1.79],0.2626763161742899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,13396,56,0.91 [0.33-2.55],0.8624891945733197
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,13685,57,0.78 [0.26-2.34],0.6610195917116108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,13260,54,1.12 [0.83-1.51],0.4422671706449772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,13433,55,0.78 [0.34-1.81],0.5630702143738504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,13685,57,0.78 [0.37-1.64],0.5099973380838455
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,13685,57,0.56 [0.22-1.46],0.234861494602197
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,13509,56,1.93 [1.25-2.98],0.0032007847059076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,13523,54,1.00 [0.59-1.71],0.9904515638755392
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,13455,55,0.88 [0.25-3.07],0.8401045332449343
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,11468,50,1.06 [0.61-1.83],0.8425585731140952
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,13183,55,1.21 [0.76-1.95],0.4224976067192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",11394,47,0.55 [0.35-0.84],0.0060768257015569
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,13680,57,0.98 [0.07-14.33],0.9862174291438608
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,13646,56,0.96 [0.58-1.60],0.8816043959626247
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,11382,49,0.92 [0.46-1.88],0.8274452120384547
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,11468,50,1.22 [0.77-1.94],0.40073522648421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,11468,50,0.94 [0.45-1.95],0.8641062212194862
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,11655,49,1.16 [0.43-3.13],0.76368699732367
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,13260,54,0.81 [0.68-0.97],0.0204179839160195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,13581,56,1.66 [0.51-5.38],0.3997820679811408
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,13437,55,1.13 [0.72-1.76],0.5896048028630836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,13183,55,1.00 [0.58-1.71],0.9975793850628046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,11376,48,1.04 [0.70-1.55],0.8365323582738379
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,13509,56,0.69 [0.34-1.38],0.2944987032516414
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,11359,47,1.13 [0.58-2.22],0.7115592563055653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,11379,48,1.57 [0.93-2.65],0.0939668998426389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,11703,50,1.15 [0.75-1.77],0.5204182333191485
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,11376,48,0.97 [0.54-1.72],0.9046002225549274
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,11700,50,2.17 [0.79-5.96],0.1336558692324246
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,13455,55,1.89 [1.13-3.15],0.0152515296275168
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,11359,47,1.35 [0.88-2.08],0.1672923206766439
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,13524,56,0.63 [0.23-1.73],0.3719822516022857
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,13660,57,1.03 [0.85-1.26],0.7371026556288929
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,13657,57,1.08 [0.75-1.56],0.6737768460959009
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,13533,56,0.95 [0.39-2.34],0.9162634789713188
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,13334,55,1.11 [0.60-2.06],0.7386786162256385
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,13426,55,0.97 [0.39-2.37],0.9385750446337708
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,13685,57,0.79 [0.35-1.80],0.5699672664258517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,13523,54,0.77 [0.37-1.61],0.485529120108439
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,11388,50,0.90 [0.61-1.34],0.6163396340695333
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,11359,47,1.45 [0.99-2.12],0.0573245065710143
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,11709,48,0.67 [0.28-1.57],0.3548180543913859
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,11296,47,0.87 [0.60-1.26],0.4633915080366859
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,11394,47,1.44 [0.85-2.45],0.1736102602882733
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,13455,55,0.89 [0.42-1.87],0.7584171983620072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,13523,54,1.82 [0.87-3.78],0.1092086163410166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,11721,50,1.05 [0.76-1.46],0.7717642247740645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,13509,56,1.07 [0.83-1.39],0.5963110234002269
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,13210,53,0.93 [0.70-1.23],0.6068019814398385
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,13260,54,0.90 [0.66-1.24],0.5171590291614585
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,13260,54,1.17 [0.85-1.61],0.3258358868289231
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,13581,56,1.24 [0.55-2.80],0.5984237073112999
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,13260,54,1.25 [0.93-1.69],0.1419763183461848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,13455,55,0.84 [0.61-1.17],0.3064199455677133
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,13680,57,0.72 [0.46-1.11],0.1395931605566422
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,13260,54,1.02 [0.53-1.96],0.9476296992349372
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,11388,50,1.16 [0.63-2.14],0.6433365435588234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,13260,54,0.94 [0.57-1.55],0.8027853245764746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,13341,55,1.82 [0.59-5.65],0.3007209798713015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,11376,48,0.98 [0.37-2.55],0.961126012213872
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,13509,56,0.52 [0.24-1.11],0.0914711235590071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,13260,54,0.80 [0.40-1.59],0.5277319156182401
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,13680,57,0.67 [0.37-1.21],0.1860157244317934
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,13245,54,0.88 [0.48-1.62],0.6809746107692031
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,13260,54,0.83 [0.56-1.24],0.3643276043647713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,13260,54,1.07 [0.53-2.17],0.8504465551574689
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,13260,54,0.80 [0.55-1.15],0.2292738828927857
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,13524,56,1.25 [0.73-2.12],0.4194001636647755
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,13330,56,0.95 [0.62-1.48],0.8350393165622295
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,13470,56,0.71 [0.42-1.19],0.1935808030402623
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,13533,56,1.07 [0.49-2.37],0.861277768318263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,13680,57,0.69 [0.34-1.41],0.3045544759468814
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,13350,54,0.89 [0.76-1.04],0.1318628192331107
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,13184,52,0.82 [0.56-1.22],0.3317096936505198
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,13260,54,0.73 [0.42-1.29],0.2828075921685118
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,13198,54,0.98 [0.63-1.51],0.92054631668511
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,13501,56,1.66 [0.57-4.81],0.3540996290244929
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,13499,56,0.64 [0.19-2.11],0.4612091967837765
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,13524,56,0.87 [0.50-1.53],0.6384655006407058
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,13634,56,1.17 [0.70-1.96],0.5554043042700032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,13260,54,0.93 [0.52-1.65],0.7962800441083043
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,13481,55,0.70 [0.43-1.13],0.1459447461530557
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,13260,54,1.67 [0.75-3.70],0.2100684331403146
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,13260,54,0.81 [0.46-1.41],0.4456315629951135
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,13260,54,1.41 [0.98-2.02],0.0612896489399197
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,11388,50,0.56 [0.29-1.08],0.0840664863638208
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,11388,50,1.34 [0.96-1.88],0.082279201402388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,11639,49,0.83 [0.53-1.32],0.4404319572386438
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,13260,54,1.16 [0.72-1.87],0.5313455163088103
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,13260,54,0.88 [0.52-1.51],0.6499992753373428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,11255,47,0.67 [0.30-1.48],0.3229140578550757
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,13417,55,1.01 [0.54-1.86],0.9864932131830914
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,13260,54,0.69 [0.33-1.43],0.3210450149025572
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,11639,49,0.52 [0.21-1.31],0.1686122269055981
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,11296,47,1.61 [0.96-2.68],0.0683553866990556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,11388,50,1.24 [0.86-1.77],0.2489444674237881
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,11347,50,0.96 [0.49-1.88],0.9044751817141156
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,13509,56,0.86 [0.48-1.52],0.5958665286854468
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,13260,54,1.22 [0.66-2.23],0.5275525119420998
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,13164,55,1.85 [0.92-3.71],0.0823519849172872
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,11388,50,1.00 [0.64-1.57],0.9968887071775694
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,11346,50,0.78 [0.49-1.23],0.2865452701363943
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,13260,54,1.21 [0.58-2.54],0.6166795848325566
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,13260,54,0.98 [0.76-1.28],0.8949125614823957
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,13509,56,0.89 [0.45-1.75],0.7267636278629709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,13260,54,1.01 [0.86-1.19],0.8912351655622832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,13509,56,1.43 [0.94-2.18],0.0956732981343715
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,13455,55,1.08 [0.79-1.46],0.6388696172962289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,13404,55,1.82 [0.92-3.61],0.0876343929921303
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,13523,54,0.48 [0.12-1.93],0.3020625038400044
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,13509,56,0.93 [0.64-1.33],0.6835893361348547
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,13524,56,1.18 [0.75-1.86],0.4701975175611759
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,11468,50,1.03 [0.66-1.61],0.8963213813967535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,13168,55,0.95 [0.63-1.44],0.8125642419344794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,11639,49,1.27 [0.75-2.16],0.3728214675695757
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,13437,55,1.36 [0.94-1.97],0.102563162543235
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,11685,50,1.37 [0.86-2.19],0.1829442441541373
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,11376,48,1.18 [0.50-2.76],0.7055757708747201
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,13154,55,0.77 [0.43-1.37],0.3759647517130845
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,11450,48,1.98 [1.20-3.26],0.0075232227372004
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,13524,56,1.17 [0.67-2.04],0.5786671156868748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,13455,55,1.50 [1.00-2.24],0.0486789986186912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",11394,47,1.23 [0.77-1.98],0.3835370184845398
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",11703,50,0.92 [0.47-1.80],0.8112317933954756
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",13455,55,1.09 [0.86-1.40],0.472739316574537
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,11685,50,1.03 [0.65-1.62],0.9009916299631148
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,11639,49,1.05 [0.67-1.65],0.8358918629232078
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,11655,49,1.00 [0.75-1.34],0.985877229234278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,11388,50,1.29 [0.26-6.46],0.7588017701181535
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,13415,54,1.05 [0.80-1.38],0.7222810616503266
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,13455,55,1.12 [0.74-1.70],0.5902720929094585
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",13293,54,0.97 [0.74-1.28],0.8465088426142375
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,13260,54,1.05 [0.75-1.48],0.7603920525900012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,13509,56,1.07 [0.85-1.34],0.5661793739236416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,12991,55,1.60 [0.86-2.97],0.1386584662967356
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,13509,56,1.08 [0.59-1.96],0.8035806175304475
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,11700,50,1.21 [0.71-2.08],0.4804044979655053
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,11578,49,1.28 [0.97-1.68],0.0846574217842371
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,13509,56,0.80 [0.40-1.58],0.5180736344831638
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,11450,48,0.95 [0.41-2.20],0.908867503848818
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,13524,56,1.02 [0.39-2.64],0.9689113932491508
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,13509,56,1.31 [0.89-1.93],0.1642018972372335
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,11388,50,1.24 [0.65-2.37],0.5160720093840752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,13524,56,0.77 [0.36-1.64],0.5020996316735595
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,13646,56,0.82 [0.20-3.39],0.783470092472351
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,11468,50,0.90 [0.54-1.51],0.6936638640976633
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,13463,55,1.60 [0.60-4.25],0.3457465860749278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,13210,53,0.79 [0.43-1.43],0.4322203602019611
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,13293,54,1.08 [0.87-1.35],0.4713242305300077
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,13425,54,0.57 [0.24-1.34],0.1970995604316289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,13554,56,1.55 [0.87-2.78],0.1397180230394065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,13260,54,0.91 [0.40-2.07],0.8252217048191172
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,13646,56,1.25 [0.77-2.05],0.3684033105590135
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,11700,50,1.43 [0.67-3.07],0.3522886906312874
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,11728,48,1.51 [0.39-5.80],0.5462205141979211
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,13533,56,2.36 [1.23-4.50],0.0095407874909689
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,11728,48,1.68 [0.71-3.99],0.2404583479931934
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,11639,49,0.95 [0.52-1.72],0.8558133436389543
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,13509,56,0.89 [0.59-1.33],0.5586858832573871
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,11359,47,1.15 [0.77-1.73],0.4883892783517493
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",11394,47,1.02 [0.70-1.49],0.9198067675144208
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",11376,48,1.57 [1.06-2.32],0.0227946506720425
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",13183,55,0.71 [0.43-1.20],0.203305628078672
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,11296,47,0.71 [0.35-1.43],0.3350383220594071
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,13653,57,1.33 [0.53-3.37],0.5434788736811504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,11450,48,1.69 [1.10-2.57],0.015576782906046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,13260,54,0.94 [0.63-1.41],0.7621418830784027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,11296,47,0.80 [0.46-1.41],0.4408971486801794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,11655,49,1.41 [1.03-1.94],0.0331684690716924
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,13260,54,0.61 [0.33-1.14],0.1245983582282027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,13455,55,1.21 [0.70-2.09],0.494833741624854
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,11655,49,1.25 [0.96-1.63],0.100326248436693
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,11376,48,0.73 [0.40-1.33],0.3080366607797329
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,11379,48,1.00 [0.71-1.43],0.9799496101879608
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,13183,55,0.74 [0.42-1.32],0.3118576559389946
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,11464,49,1.53 [0.93-2.52],0.0940190684993339
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,11388,50,0.81 [0.55-1.18],0.2711849112230643
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,13554,56,1.31 [0.52-3.28],0.5648137367631856
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,13183,55,0.86 [0.44-1.67],0.6496740094098341
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,11296,47,1.03 [0.70-1.52],0.8744156629303783
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,11394,47,1.28 [0.83-1.96],0.2587883950782954
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,11685,50,0.67 [0.26-1.69],0.3935167032329602
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,11468,50,1.11 [0.77-1.61],0.5621216279373086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,11468,50,1.10 [0.44-2.79],0.8350706820854947
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,11639,49,0.96 [0.58-1.57],0.8642704543387777
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,11359,47,0.98 [0.46-2.11],0.9639831746162338
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,11376,48,0.77 [0.52-1.16],0.2131831494458597
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,11359,47,1.32 [1.03-1.68],0.0284393086068141
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,13455,55,1.10 [0.82-1.47],0.5200706307814706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,11639,49,0.87 [0.63-1.20],0.389494110772719
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,13210,53,0.83 [0.59-1.15],0.2617684433403855
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,11655,49,0.86 [0.73-1.03],0.0942281105090775
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,13210,53,1.18 [0.96-1.44],0.1119737420044705
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,11296,47,1.07 [0.80-1.43],0.6328808973135056
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,11376,48,0.70 [0.37-1.31],0.261651727634706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,13183,55,1.29 [0.73-2.28],0.3854603432337108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,13515,56,1.03 [0.47-2.29],0.9350282724800216
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,13523,54,2.15 [1.07-4.33],0.0316168945477286
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,13183,55,1.02 [0.74-1.41],0.90189329603005
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,11376,48,0.62 [0.30-1.31],0.2138242864435295
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,11703,50,1.33 [0.86-2.06],0.2036598999698747
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,13379,56,1.07 [0.90-1.28],0.4488980291627815
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,13516,56,0.83 [0.45-1.51],0.5355664060771894
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,13416,56,1.81 [0.91-3.58],0.0889839433335189
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,13210,53,0.98 [0.83-1.16],0.8008679054838687
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,13220,55,0.82 [0.47-1.44],0.4914185633282595
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,13646,56,1.11 [0.67-1.83],0.6955331611636395
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,11623,49,1.87 [1.18-2.95],0.0075304375610642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,11700,50,0.90 [0.56-1.44],0.6660338331049654
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,13646,56,1.03 [0.70-1.50],0.8978677570227988
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,13543,56,1.60 [0.72-3.57],0.2466009775127295
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,11119,47,1.42 [0.73-2.77],0.2983419113037525
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,13059,55,0.79 [0.40-1.59],0.5123203025032416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,11501,47,1.49 [0.52-4.26],0.4615511634935686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,13680,57,1.01 [0.53-1.92],0.9829505800391896
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,11376,48,0.91 [0.56-1.49],0.7189966496758775
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,13680,57,0.71 [0.43-1.19],0.1951506401471438
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,11388,50,1.13 [0.64-2.01],0.6705165288136221
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,11685,50,1.17 [0.64-2.14],0.6126483775098713
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",12755,55,0.47 [0.18-1.24],0.1293994058156623
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",11359,47,1.16 [0.60-2.23],0.6627852441691255
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",13455,55,0.94 [0.68-1.29],0.6862635044265579
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",13493,56,0.99 [0.69-1.43],0.9744061219877422
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",13183,55,0.97 [0.59-1.60],0.9072368405768052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",11359,47,1.09 [0.59-2.02],0.7829528600444606
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",11376,48,0.72 [0.39-1.32],0.2868013899064256
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,13492,53,1.18 [0.78-1.78],0.4330057899697567
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,13680,57,0.59 [0.34-1.02],0.0567857536462847
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,13554,56,1.43 [0.62-3.27],0.4026443033922203
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,11721,50,1.40 [1.05-1.87],0.0210842221775974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,11623,49,1.20 [0.75-1.91],0.4488693455495707
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,13523,54,1.17 [0.82-1.66],0.391389290128038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,13455,55,0.75 [0.41-1.39],0.3677206579594357
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,13519,56,1.25 [0.70-2.22],0.4558858362939598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,13437,55,0.99 [0.79-1.25],0.9521312195232288
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,11359,47,0.97 [0.58-1.62],0.9004446171801036
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,13581,56,1.36 [0.69-2.67],0.3782950525452437
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,11394,47,2.27 [0.89-5.84],0.0876011973856507
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,11391,49,0.68 [0.20-2.27],0.5342608667819991
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,13112,56,1.47 [0.40-5.39],0.5604017971805098
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,13653,57,0.97 [0.62-1.53],0.9018052812093652
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,11639,49,1.19 [0.67-2.12],0.5606127660578729
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,13260,54,1.26 [0.80-1.97],0.3170443043351953
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,11639,49,1.15 [0.80-1.66],0.4571347616755667
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,13680,57,1.16 [0.85-1.59],0.3424901095129841
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,13455,55,1.13 [0.93-1.37],0.2209742505536184
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,11388,50,1.21 [0.88-1.65],0.2394481747110278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,13408,55,1.08 [0.51-2.27],0.8460330041799817
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,13533,56,0.83 [0.56-1.24],0.3585890979519733
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,13653,57,1.03 [0.74-1.44],0.8422826034334714
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,11717,49,1.94 [0.56-6.66],0.2936781304086366
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,11703,50,0.93 [0.59-1.45],0.7409988153330247
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,13053,52,0.99 [0.50-1.96],0.984217643420632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,11700,50,1.22 [0.72-2.06],0.4549005650229552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,13560,56,1.06 [0.68-1.66],0.803544514703803
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,11703,50,1.40 [1.05-1.85],0.0204244257093671
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,11721,50,1.23 [0.84-1.81],0.2918490998160519
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,13625,56,1.25 [0.83-1.89],0.2907726264596344
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,11052,46,0.79 [0.51-1.21],0.2698189558668429
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,11376,48,0.57 [0.36-0.90],0.0149170569921139
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,11703,50,1.35 [0.74-2.47],0.3293510426692541
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEP,Leptin,13523,54,0.94 [0.65-1.35],0.7408792980923714
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,13523,54,1.06 [0.49-2.29],0.8814026901829669
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,11703,50,1.56 [1.01-2.39],0.0441393024923108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,13523,54,1.24 [0.61-2.53],0.5498773123014233
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,13555,56,1.37 [0.62-3.02],0.4384725156279865
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,11728,48,1.52 [0.72-3.22],0.2698254101348917
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,13519,56,1.05 [0.67-1.65],0.8389552567889473
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,13511,56,0.84 [0.46-1.56],0.5879683178393897
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,13653,57,1.43 [1.00-2.05],0.0525545828274327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,13509,55,0.58 [0.27-1.26],0.1686150684876001
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,13581,56,1.24 [0.66-2.34],0.5102112901475115
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,13210,53,0.85 [0.62-1.17],0.3111496233235747
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,13532,56,1.04 [0.71-1.54],0.8252077912274296
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,13183,55,1.04 [0.67-1.61],0.8716919308322686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,13509,56,0.93 [0.35-2.46],0.8838618556256007
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,13524,56,1.15 [0.60-2.23],0.6741814447262671
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,11700,50,1.06 [0.84-1.33],0.6303069337503073
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,11359,47,1.27 [0.82-1.97],0.2790845567291783
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,13505,54,1.23 [0.58-2.62],0.5945427685625346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,11721,50,0.79 [0.55-1.14],0.2083357412866861
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,13685,57,0.88 [0.38-2.07],0.7747533583141009
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,13606,56,0.75 [0.39-1.45],0.3977643581252994
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,13260,54,0.79 [0.44-1.41],0.4200972821175326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,13685,57,0.94 [0.68-1.30],0.7216207396312044
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,11394,47,1.37 [0.88-2.15],0.1673516004012192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,11630,49,0.93 [0.59-1.48],0.7672396695270431
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,11685,50,1.20 [0.46-3.10],0.7114020595893142
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,11703,50,0.85 [0.37-1.92],0.6915046202842617
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,11376,48,0.87 [0.55-1.37],0.5451476089697092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",11394,47,1.18 [0.87-1.61],0.2933855570933745
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),11424,46,0.98 [0.83-1.15],0.7890709312126055
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,13455,55,1.03 [0.60-1.78],0.913991727983981
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,13523,54,1.14 [0.68-1.93],0.6132819708935181
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,13110,52,0.73 [0.48-1.11],0.1387066486691205
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,11359,47,1.38 [0.93-2.04],0.1082243745250038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,11359,47,1.36 [0.96-1.93],0.0817013143698175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,11379,48,0.94 [0.53-1.67],0.8388164912292836
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,11728,48,0.76 [0.27-2.16],0.6014239937858069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,13609,56,1.18 [0.60-2.33],0.6396689672347545
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,11345,50,1.36 [0.65-2.86],0.4142771730790624
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,13455,55,1.80 [0.78-4.19],0.171383996335325
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,13523,54,0.97 [0.48-1.97],0.9364591686514896
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,11379,48,1.03 [0.49-2.16],0.9378241741458884
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,11379,48,0.79 [0.52-1.21],0.281180899122529
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,13653,57,1.25 [0.88-1.78],0.212243826546813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,13455,55,1.40 [0.83-2.38],0.2069775817382671
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,11655,49,0.95 [0.50-1.80],0.866526340039062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,11379,48,1.03 [0.59-1.78],0.9212562977584412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,11721,50,1.72 [1.05-2.80],0.0303171616080526
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,11639,49,1.26 [0.75-2.12],0.384547792449748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,13260,54,1.02 [0.54-1.92],0.946611948952137
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,11379,48,1.62 [1.02-2.58],0.0400691189187712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,11703,50,1.50 [0.71-3.18],0.290231365848243
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,13210,53,1.14 [0.79-1.66],0.4804287258635629
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,11468,50,0.88 [0.62-1.25],0.4780961400343401
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,13509,56,0.91 [0.51-1.64],0.7600964073777
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,13509,56,0.64 [0.35-1.14],0.1289817608712452
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,13646,56,1.35 [0.94-1.95],0.1087281833441519
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,11639,49,0.98 [0.45-2.14],0.9647803375280056
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,13685,57,1.21 [0.57-2.56],0.6218122309575983
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,13210,53,1.10 [0.72-1.66],0.6624210758792894
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,13440,55,1.26 [0.51-3.07],0.6179612329873949
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,13260,54,0.82 [0.43-1.53],0.5262048647001667
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,11639,49,0.97 [0.53-1.80],0.9338151319423864
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LXN,Latexin,13372,55,1.05 [0.74-1.48],0.790169778707278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,13432,54,0.69 [0.34-1.41],0.3114253788726988
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,13509,56,1.09 [0.59-2.01],0.787907476254345
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,13400,57,0.45 [0.19-1.05],0.0643007579964212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,13437,55,1.50 [0.80-2.80],0.2061170750915604
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,13210,53,0.84 [0.50-1.42],0.5169718953242144
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,13455,55,1.31 [0.99-1.75],0.0629072632724903
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,13183,55,1.01 [0.70-1.44],0.9625779095354556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,13450,55,0.82 [0.41-1.67],0.5904241895264903
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,13210,53,0.86 [0.52-1.42],0.5482559485964549
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,11376,48,1.23 [1.01-1.49],0.0376676042973388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,11379,48,1.07 [0.83-1.38],0.5832390492093602
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,11728,48,0.84 [0.20-3.42],0.8037876592303603
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,11296,47,1.58 [0.91-2.73],0.1038185660986756
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,11450,48,1.32 [0.90-1.92],0.1530747254669854
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,11394,47,1.13 [0.62-2.05],0.6923765702996347
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,13391,55,1.01 [0.62-1.64],0.9665928733029192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,13210,53,1.03 [0.56-1.87],0.931203717187704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,11379,48,0.78 [0.43-1.39],0.3933300812660676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,11468,50,1.13 [0.81-1.56],0.4707513494410585
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,13210,53,1.37 [0.87-2.15],0.1786003822065242
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,11721,50,1.07 [0.47-2.43],0.8659053014285033
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,11639,49,0.73 [0.44-1.23],0.2355488252902346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",11394,47,1.74 [0.60-5.06],0.3113895711969302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,11721,50,0.81 [0.52-1.27],0.3516512932751996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",11296,47,1.37 [0.83-2.24],0.2162207260950358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,13581,56,1.12 [0.91-1.37],0.2919964866459709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,13554,56,1.76 [0.76-4.05],0.1859043251661043
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,11359,47,0.86 [0.54-1.36],0.5197716610675014
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,11376,48,1.31 [0.57-2.99],0.5208835889284918
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,11359,47,0.72 [0.40-1.32],0.291789410501825
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,11685,50,1.40 [0.83-2.37],0.2038373894173685
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,11655,49,1.40 [0.94-2.09],0.0999729210457964
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,13509,56,1.09 [0.86-1.38],0.4653423338188975
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,13210,53,1.02 [0.80-1.30],0.8799444464926438
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,13408,55,1.15 [0.92-1.42],0.2190719748582184
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,11296,47,0.93 [0.49-1.77],0.8257701436487186
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,13509,56,1.01 [0.59-1.72],0.9801105499093016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,11468,50,1.43 [1.02-2.00],0.0376606055121361
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,11296,47,0.98 [0.79-1.20],0.81018006739326
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,13183,55,0.90 [0.58-1.39],0.6348758696384124
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,13523,54,0.72 [0.30-1.76],0.4748192336018935
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",11421,48,1.26 [0.92-1.73],0.1563969982537383
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,13408,55,1.16 [0.42-3.19],0.768759814299412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,13544,56,0.77 [0.35-1.69],0.5212358356859697
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,13415,54,1.61 [0.74-3.48],0.2258161556731813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,13210,53,1.07 [0.83-1.39],0.5971705538155955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MAX,Protein max,13183,55,1.14 [0.91-1.43],0.268103741129317
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,13685,57,0.82 [0.49-1.36],0.4336224398926899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,11555,48,0.96 [0.75-1.24],0.7657784316511563
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,13533,56,1.26 [0.64-2.48],0.5041012593230962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",11703,50,1.32 [0.83-2.10],0.2334540858150514
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,11388,50,1.21 [0.92-1.59],0.1653489884428275
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,13475,54,1.32 [0.77-2.26],0.3066380931137779
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,11655,49,0.49 [0.14-1.71],0.2614854036780648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,13437,55,1.01 [0.72-1.41],0.957624912814388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",11642,48,1.26 [0.68-2.36],0.4615756668617506
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MDK,Midkine,13513,56,0.97 [0.61-1.55],0.9116231877023652
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,11379,48,1.65 [0.76-3.59],0.2096700285477186
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",11394,47,1.34 [1.00-1.80],0.0483635646591133
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,13210,53,1.09 [0.79-1.50],0.5910821128783552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,11359,47,1.30 [0.85-2.00],0.2244618088703533
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,13519,56,1.11 [0.61-2.01],0.7323842341798654
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,11359,47,1.29 [0.64-2.60],0.4774335953963207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,13634,56,0.91 [0.31-2.69],0.8663301929463652
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,11721,50,1.08 [0.42-2.72],0.878079042051073
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,11450,48,5.34 [1.49-19.10],0.0099989989604701
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,11655,49,0.96 [0.64-1.44],0.8408399706550385
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,13523,54,0.95 [0.78-1.16],0.6299305525265451
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,13519,56,1.03 [0.42-2.54],0.9492100341713546
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,13680,57,1.24 [0.51-2.97],0.636479176684362
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,13524,56,1.13 [0.93-1.37],0.2068063572732947
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,13556,57,0.62 [0.19-2.01],0.4235329689343053
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,13183,55,0.55 [0.23-1.29],0.1662698208834711
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",13509,56,1.20 [0.91-1.58],0.2050275286579682
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,13625,56,1.09 [0.73-1.62],0.6886922910694336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,13293,54,0.75 [0.43-1.30],0.3108720051008974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,11379,48,1.04 [0.70-1.53],0.8523650690438737
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,11450,48,1.62 [0.68-3.88],0.2783920137567224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,13685,57,0.54 [0.31-0.92],0.0248240244001831
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,13524,56,0.64 [0.36-1.14],0.1284920381148985
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,13560,56,1.13 [0.86-1.49],0.3806294522263626
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,13509,56,1.12 [0.92-1.37],0.2581646384483993
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,13554,56,0.87 [0.45-1.68],0.6746679507721254
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,11379,48,1.32 [0.96-1.82],0.0867037514439276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,13509,56,0.95 [0.82-1.10],0.5062879739295212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,13502,55,1.10 [0.78-1.56],0.5827982798747718
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,13260,54,0.71 [0.43-1.18],0.1823682597043653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,11639,49,1.28 [0.99-1.64],0.0601299003624657
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,11685,50,1.33 [0.99-1.79],0.0618932242441186
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,13437,55,1.16 [0.90-1.50],0.2392128049473348
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,11388,50,1.18 [0.65-2.13],0.5834695797737481
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,11296,47,0.88 [0.58-1.34],0.5565864328046077
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,13509,56,0.96 [0.73-1.25],0.7456557145861674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,13455,55,1.13 [0.85-1.50],0.3950498246036638
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,13008,55,1.03 [0.80-1.34],0.8008395067366046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,13508,56,0.95 [0.64-1.39],0.7830510543560956
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,13544,56,0.86 [0.54-1.38],0.5389805989952436
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,13183,55,1.12 [0.53-2.34],0.771752614051037
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,11721,50,1.20 [0.80-1.81],0.379815003683315
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,13524,56,1.03 [0.62-1.70],0.9208539852787936
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,13267,54,0.71 [0.44-1.13],0.1495897302318801
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,13633,57,1.05 [0.77-1.43],0.7624270405601543
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,13503,56,1.02 [0.70-1.49],0.9107434858732828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",11359,47,1.45 [0.90-2.34],0.122211073446518
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,11379,48,1.27 [0.89-1.82],0.1915830961737306
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,11468,50,1.58 [1.05-2.38],0.027660646753437
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,13505,54,0.91 [0.70-1.17],0.4492926703356933
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,11450,48,1.10 [0.73-1.65],0.6459397285801409
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,13646,56,1.11 [0.52-2.35],0.7874263736170091
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,11685,50,1.91 [1.10-3.29],0.020675811566221
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,11468,50,0.73 [0.34-1.58],0.4192584424213084
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,11296,47,0.95 [0.44-2.05],0.8930811325580079
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,11296,47,0.87 [0.59-1.29],0.4803835304413254
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,13293,54,1.24 [0.92-1.68],0.1600689772504085
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,13455,55,1.20 [0.92-1.57],0.1859160142577193
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,13560,56,1.03 [0.76-1.41],0.8291303659238227
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,13524,56,1.02 [0.63-1.67],0.9269892892315758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,11617,49,1.03 [0.56-1.89],0.9251734224457886
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,11717,49,1.09 [0.41-2.89],0.8696178043006388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,11379,48,0.99 [0.66-1.48],0.9535897907970584
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",11359,47,1.50 [1.03-2.19],0.032959729746939
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",11703,50,0.80 [0.32-2.02],0.6401675231834594
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",13183,55,1.54 [0.73-3.26],0.2547828612924971
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",11282,47,0.96 [0.32-2.89],0.9428880512706532
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",11703,50,1.16 [0.84-1.60],0.3648191116616314
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",11388,50,1.17 [0.51-2.66],0.7076472779205907
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,13441,55,1.03 [0.66-1.59],0.9048139856674514
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,11379,48,1.11 [0.54-2.29],0.7677969540130001
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,13473,57,1.20 [0.85-1.71],0.3013050789912946
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,13653,57,0.89 [0.54-1.47],0.6518745869276017
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,13554,56,1.23 [0.89-1.69],0.2078828420640435
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,11536,48,0.83 [0.60-1.16],0.2855740040097726
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,13293,54,0.93 [0.58-1.50],0.7759202070674349
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,11388,50,1.36 [1.01-1.82],0.0419071345670794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",11685,50,1.24 [0.47-3.26],0.6583792167443642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,11468,50,1.19 [0.94-1.51],0.1528270738171247
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",11655,49,1.40 [1.04-1.88],0.0270871174449712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,13293,54,1.51 [0.93-2.44],0.09674436478641
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,11359,47,0.97 [0.63-1.50],0.894981390974013
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,11655,49,1.09 [0.85-1.39],0.5109127111764599
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,11639,49,1.24 [0.95-1.62],0.1190851407530913
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,11468,50,1.04 [0.66-1.65],0.8671179296894448
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,13183,55,1.16 [0.71-1.88],0.5503230005333803
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,13455,55,0.99 [0.87-1.12],0.8142869011707268
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,11700,50,0.91 [0.67-1.23],0.5272237205383529
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,11296,47,1.04 [0.58-1.87],0.902945073417346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,13260,54,1.06 [0.78-1.45],0.7100108403631638
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,11450,48,1.50 [0.60-3.76],0.3828150126118789
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",11721,50,0.87 [0.55-1.36],0.5383863300398357
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",11394,47,1.13 [0.84-1.51],0.4237827913683575
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,11703,50,0.97 [0.66-1.44],0.8941604790383124
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,11721,50,1.36 [1.05-1.76],0.0207761904498612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,11359,47,1.46 [1.01-2.13],0.0457420621318231
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,11296,47,0.95 [0.51-1.79],0.8769242708284204
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,11700,50,1.16 [0.92-1.48],0.209700422546819
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",11359,47,0.99 [0.50-1.99],0.987596422907408
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,11394,47,0.94 [0.62-1.43],0.7835045447152351
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,11394,47,0.75 [0.41-1.36],0.3395338289489903
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,11379,48,1.07 [0.81-1.42],0.621529079148967
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",11379,48,0.85 [0.41-1.76],0.6663331710825222
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,11703,50,0.99 [0.48-2.02],0.9686490516238402
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,13260,54,1.01 [0.71-1.44],0.9446609082750052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,13524,56,0.94 [0.56-1.56],0.8026293248367042
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,11376,48,0.48 [0.21-1.08],0.0746460561681592
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,11359,47,0.88 [0.47-1.65],0.6796042775999551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,11450,48,0.74 [0.54-1.02],0.0666429204934918
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,13565,56,0.66 [0.40-1.09],0.1047624936105974
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,13210,53,1.07 [0.69-1.65],0.7641537706423588
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,11359,47,1.78 [1.13-2.82],0.0135748558397084
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,11379,48,1.31 [1.04-1.65],0.0207319015409213
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,13375,55,1.13 [0.77-1.65],0.5415644966571735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,11639,49,1.29 [0.83-1.99],0.260991615333218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,13523,54,0.66 [0.41-1.08],0.1012137796372111
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,11368,50,1.08 [0.72-1.63],0.7021068393319712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,11370,47,1.39 [0.88-2.18],0.1584333642778276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,11450,48,0.92 [0.25-3.33],0.895315932595054
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,13210,53,0.93 [0.58-1.49],0.7477416589582304
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,11641,49,1.39 [0.71-2.73],0.3418738079879629
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,11685,50,1.35 [0.64-2.84],0.4304569649913904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",11703,50,1.39 [0.78-2.49],0.262942560002505
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,13554,56,1.14 [0.45-2.90],0.7893419574550727
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,13260,54,0.89 [0.54-1.47],0.6469404616345018
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,13533,56,1.61 [0.71-3.64],0.2534987623418694
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,13524,56,2.78 [1.17-6.59],0.0200146812423636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,13653,57,1.63 [0.86-3.10],0.1326458436807373
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,13493,56,0.94 [0.71-1.24],0.6512474369664625
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,13581,56,1.16 [0.93-1.45],0.1942115783044007
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,13260,54,0.82 [0.48-1.40],0.4587821462337289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,13489,56,1.39 [0.71-2.69],0.3338540896153577
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,11655,49,1.06 [0.46-2.45],0.8927942816735203
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,13646,56,0.56 [0.24-1.28],0.169329670962397
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,13183,55,0.80 [0.53-1.22],0.307556654185688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,11639,49,1.29 [0.95-1.76],0.1005870915041471
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,11365,50,1.18 [0.56-2.51],0.6613946076095077
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,11655,49,1.30 [0.97-1.75],0.0794051913121664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",13210,53,1.07 [0.81-1.41],0.6521450469872966
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,11359,47,1.15 [0.58-2.31],0.6870707876693996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,11359,47,1.57 [1.14-2.18],0.0061772775183273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,11388,50,0.44 [0.17-1.13],0.087080629894162
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,13505,54,1.69 [0.73-3.91],0.2194598861829969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,13554,56,1.35 [0.60-3.04],0.4739130820946287
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,11388,50,1.41 [0.77-2.57],0.2602852281207445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,11388,50,1.23 [0.61-2.48],0.5687209568822
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,13139,55,1.31 [0.74-2.33],0.3500964355937148
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,11468,50,1.19 [0.89-1.59],0.2370683436306349
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,13554,56,0.73 [0.41-1.30],0.281869033098749
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,13581,56,1.33 [0.59-2.99],0.4942713778184204
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,11639,49,1.04 [0.82-1.32],0.7413215981731971
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,11703,50,0.65 [0.18-2.35],0.5092612431316899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,11717,49,1.36 [0.95-1.97],0.0944250467499037
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,13680,57,0.54 [0.22-1.30],0.1689956785474874
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,11388,50,1.06 [0.79-1.43],0.6794399142789573
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",13509,56,1.13 [0.89-1.45],0.3099682815265748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",13260,54,0.63 [0.40-1.02],0.0592544620714799
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,11394,47,1.29 [0.91-1.85],0.1571308697947029
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,11703,50,1.37 [0.92-2.04],0.1202868624465733
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,11359,47,1.34 [0.93-1.94],0.1215752131541031
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,11468,50,0.90 [0.54-1.51],0.6842610906452913
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,13210,53,1.02 [0.62-1.68],0.9455492275281878
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",11655,49,1.34 [1.03-1.74],0.0295540783186371
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,11359,47,1.63 [1.22-2.18],0.0009394798025021
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,11359,47,1.39 [0.80-2.42],0.2427770162388067
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,13437,55,0.84 [0.13-5.60],0.8593706699125133
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,11721,50,1.27 [0.61-2.65],0.5265299798264496
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,11685,50,1.39 [0.46-4.18],0.56048887370308
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,11158,46,0.85 [0.35-2.05],0.7145962758555207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,13494,56,1.31 [0.73-2.35],0.3616512495455144
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,13524,56,1.18 [0.87-1.61],0.2892505429157668
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,13210,53,0.62 [0.34-1.13],0.1178824064952721
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,11394,47,1.73 [0.92-3.25],0.0895145719806674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,11686,50,1.33 [0.94-1.88],0.1127065695123861
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,11379,48,1.04 [0.71-1.52],0.8463725500254718
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,11376,48,1.36 [0.88-2.10],0.1637059738460937
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,11388,50,2.06 [0.70-6.06],0.1896508770329592
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,13544,56,1.25 [0.50-3.12],0.63059415614421
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,11597,49,1.06 [0.74-1.54],0.74094849032509
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,13437,55,0.89 [0.63-1.26],0.5268788767251258
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,11296,47,0.94 [0.48-1.85],0.8581708570010289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,11703,50,1.53 [1.18-1.99],0.001475689418768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,13524,56,0.85 [0.32-2.26],0.7420552781283671
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,11359,47,1.24 [1.03-1.49],0.0215038941519229
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",13183,55,1.06 [0.66-1.70],0.8220880749574707
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",11359,47,1.16 [0.59-2.28],0.6761005860646501
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",13183,55,1.12 [0.73-1.72],0.595512233775894
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,13685,57,0.86 [0.19-3.84],0.8390871105531696
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,11700,50,0.87 [0.26-2.97],0.8270372645765642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,13685,57,0.86 [0.44-1.68],0.6604341945792358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,11511,49,1.01 [0.42-2.44],0.980177700869872
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,13523,54,1.65 [0.77-3.52],0.1949699877000912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,11388,50,1.29 [0.66-2.53],0.4610845212809018
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,11388,50,1.04 [0.82-1.33],0.7518499232720697
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,11721,50,1.31 [0.72-2.39],0.3831406800182839
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,13293,54,1.05 [0.86-1.28],0.6340822121413794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,13509,56,0.88 [0.49-1.56],0.6556944495606833
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,11359,47,1.35 [0.76-2.40],0.3131396407223075
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,13210,53,1.20 [0.97-1.48],0.0877259771028105
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,13524,56,1.27 [0.71-2.28],0.4153547568306747
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,11700,50,2.40 [1.12-5.17],0.0252046609844576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,13523,54,0.99 [0.49-1.99],0.9783573448645272
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,13646,56,0.87 [0.62-1.22],0.4208816744955715
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,13523,54,0.86 [0.36-2.07],0.7373605696147214
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,11717,49,1.34 [0.99-1.80],0.0569048474936344
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,11703,50,1.15 [0.61-2.19],0.667925286102705
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,13562,56,1.15 [0.50-2.65],0.7388054515796556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,13524,56,0.91 [0.40-2.06],0.8195943781603997
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,13260,54,1.02 [0.63-1.65],0.9438293511936268
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,11379,48,1.40 [0.73-2.69],0.3175343836100058
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,13653,57,1.07 [0.76-1.51],0.7019679923279558
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",11721,50,1.39 [0.97-1.98],0.0694556705739985
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,11685,50,0.55 [0.21-1.44],0.2221745303325044
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,13490,56,1.09 [0.84-1.43],0.5164766302016746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,13554,56,1.02 [0.67-1.54],0.930685590065616
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,13509,56,0.92 [0.46-1.81],0.8003463137399409
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,13210,53,0.86 [0.43-1.73],0.6780297799064079
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,13523,54,1.15 [0.45-2.93],0.7687842474777504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,13653,57,1.77 [0.60-5.22],0.298529518175556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,13523,54,1.03 [0.79-1.34],0.8151282410168403
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,13509,56,1.14 [0.87-1.49],0.347394276073367
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,11639,49,1.01 [0.76-1.33],0.9617119850964
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,13621,56,1.36 [0.74-2.49],0.322332400146119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,13680,57,1.17 [0.81-1.68],0.4098325767340381
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,11394,47,1.43 [0.69-2.96],0.3310064055073765
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,11359,47,0.92 [0.52-1.61],0.7609721505842849
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,11636,49,1.36 [1.01-1.82],0.0399897275408015
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],13455,55,1.10 [0.74-1.63],0.633724348131481
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,13524,56,1.16 [0.74-1.80],0.5190903297728561
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,11388,50,1.41 [1.01-1.97],0.0405583751462863
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,11359,47,0.95 [0.41-2.24],0.9135578558132238
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,11359,47,0.75 [0.30-1.86],0.5319117454722087
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,13183,55,1.25 [0.70-2.23],0.449170543747737
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,11388,50,3.36 [1.40-8.07],0.0066602084931598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,13392,54,1.11 [0.78-1.60],0.5588935171481213
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,11703,50,1.05 [0.57-1.95],0.8682953795177485
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,13164,55,0.79 [0.48-1.32],0.370942987199867
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,11468,50,1.02 [0.69-1.51],0.9087807113989932
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,11655,49,1.31 [0.90-1.91],0.1626095958384257
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,13455,55,0.88 [0.42-1.82],0.7222233717238573
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,13524,56,0.90 [0.49-1.66],0.7412015785891344
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,11468,50,1.08 [0.72-1.62],0.7123989491996365
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,11023,46,0.85 [0.68-1.07],0.1668850527603195
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,13375,50,0.97 [0.64-1.47],0.887899309251851
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,13581,56,0.97 [0.58-1.63],0.9180664325358422
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,13455,55,1.18 [0.81-1.73],0.3894732914141489
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,11376,48,0.53 [0.26-1.09],0.0830351050108417
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,11685,50,1.23 [0.96-1.59],0.1042666025360016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,11394,47,1.28 [0.87-1.87],0.2134151557500069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,13455,55,1.00 [0.59-1.71],0.9871169530775016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,11688,48,1.11 [0.28-4.34],0.8858273535120651
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,11685,50,0.60 [0.25-1.45],0.2547494760691776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,13544,56,1.86 [0.90-3.84],0.0934649228259146
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,13435,55,0.97 [0.70-1.34],0.8560017371568711
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,13562,56,0.86 [0.28-2.64],0.7973908731685339
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,11379,48,1.26 [0.78-2.06],0.3478032605659882
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,11376,48,0.86 [0.48-1.53],0.6005239200765353
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,11655,49,1.63 [1.04-2.54],0.0320432940794395
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,11703,50,1.39 [0.94-2.07],0.1023918175211173
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",11394,47,1.31 [0.89-1.92],0.1727751921716677
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,13653,57,0.96 [0.80-1.14],0.6204134032174423
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,13446,55,1.60 [0.89-2.91],0.1189381769526489
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,11359,47,1.55 [1.02-2.34],0.0382271110073266
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,13260,54,0.88 [0.55-1.41],0.5870244441913872
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,13164,55,1.02 [0.74-1.41],0.8977878697660574
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,13437,55,1.11 [0.95-1.30],0.1937674194074986
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,11703,50,1.02 [0.82-1.28],0.8504249952834917
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",11468,50,1.28 [0.78-2.11],0.3342438192390636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,13293,54,1.20 [0.80-1.82],0.383207471944847
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,11394,47,1.09 [0.60-1.98],0.7683783444366987
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,11273,47,1.03 [0.61-1.75],0.8997377287732768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,13183,55,1.20 [0.85-1.71],0.3023327047803307
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,11388,50,1.16 [0.63-2.13],0.6239269534158067
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,11598,49,1.11 [0.43-2.85],0.8299818749301767
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,11685,50,1.10 [0.54-2.23],0.7956928667546346
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,11359,47,1.08 [0.77-1.50],0.6714595367550987
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,13608,57,1.58 [0.65-3.84],0.3076292915785416
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,13524,56,1.05 [0.46-2.43],0.906082814925404
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,13260,54,0.91 [0.54-1.53],0.7100005798038136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,11468,50,1.12 [0.80-1.56],0.5211158630157553
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,13524,56,1.12 [0.73-1.73],0.597790213485513
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,13509,56,0.87 [0.53-1.41],0.5649271611097273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,11450,48,1.43 [0.83-2.48],0.1982358357280738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,11296,47,0.88 [0.35-2.20],0.7896060822459531
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,13183,55,0.98 [0.60-1.58],0.925156562936867
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,11655,49,0.56 [0.20-1.55],0.2639973541859521
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,11376,48,0.94 [0.67-1.32],0.7110127447197667
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,11420,47,0.89 [0.48-1.66],0.7196955146083664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,11703,50,1.36 [0.94-1.97],0.1015486717207153
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,13638,57,0.62 [0.19-2.05],0.4385625951986407
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,11703,50,0.65 [0.22-1.90],0.4296557045445384
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,13523,54,0.59 [0.28-1.22],0.1565668160236122
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,11655,49,1.28 [0.65-2.53],0.4732829282331399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,11655,49,1.40 [0.63-3.13],0.4076122576094224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,11639,49,1.27 [0.69-2.34],0.4439933876530658
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,11296,47,1.14 [0.79-1.63],0.4805349738758125
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,11639,49,1.59 [1.03-2.47],0.0384251044278768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,13685,57,0.94 [0.52-1.71],0.8505929150681901
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,11655,49,1.41 [1.00-1.99],0.0531816345775454
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,11721,50,1.31 [1.00-1.72],0.0533557196006863
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,13629,56,0.76 [0.42-1.39],0.378225442050358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,13455,55,1.19 [0.56-2.54],0.646012503638919
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,13653,57,1.08 [0.73-1.60],0.6858858476562366
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,13523,54,1.26 [0.83-1.93],0.279517383923526
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,11296,47,0.95 [0.56-1.63],0.8597182840469755
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",11296,47,1.19 [0.81-1.74],0.3747578614172265
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",11359,47,1.26 [0.90-1.76],0.1768131783011107
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",11450,48,1.18 [0.90-1.56],0.2310893515752689
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,13685,57,1.12 [0.81-1.54],0.5018759524727123
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,13581,56,1.09 [0.83-1.43],0.5435294014619128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,13210,53,0.80 [0.34-1.84],0.592831626287091
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,13523,54,0.94 [0.40-2.19],0.8875600950325
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,13685,57,2.05 [1.01-4.13],0.0453897100290124
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,11296,47,1.23 [0.65-2.33],0.5270600121071984
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,11450,48,1.45 [0.71-2.94],0.3064002307927355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,11700,50,1.39 [0.92-2.10],0.1197207745411686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,11296,47,1.25 [0.88-1.79],0.2176535558583192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,11703,50,1.24 [0.97-1.57],0.0823625564547031
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,13581,56,1.08 [0.90-1.29],0.4276477524953302
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",13210,53,0.97 [0.60-1.55],0.8914673986241166
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,11379,48,0.92 [0.54-1.59],0.7764988626381668
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,11296,47,1.30 [0.99-1.71],0.0620805205077744
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,11359,47,1.32 [0.89-1.94],0.1645370756226259
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,11388,50,1.26 [0.73-2.17],0.3998097852357489
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,13685,57,2.07 [0.73-5.83],0.1707652679707016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,13524,56,1.04 [0.70-1.53],0.8571448132979029
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,13524,56,1.57 [0.75-3.32],0.2343112249661527
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,11394,47,1.63 [0.80-3.31],0.1803950192374886
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,11450,48,1.48 [0.64-3.42],0.3565094070321377
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,11717,49,1.11 [0.38-3.23],0.8449516945283138
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,11388,50,1.22 [0.98-1.52],0.0781888075659451
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,11639,47,1.14 [0.87-1.49],0.3527742612568137
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,13183,55,1.20 [0.80-1.81],0.3709295391102122
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,11296,47,0.67 [0.36-1.23],0.1980641531646512
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,11379,48,0.94 [0.61-1.46],0.7866224179951489
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",13436,55,0.97 [0.71-1.32],0.8302579345949621
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,11717,49,1.36 [0.88-2.09],0.1663160012020924
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",11721,50,1.30 [0.82-2.07],0.2641121535927343
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,13680,57,0.44 [0.15-1.24],0.1187941733825961
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,13606,56,1.28 [0.76-2.15],0.3629656690844218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,11569,47,1.48 [0.61-3.62],0.3851131776548557
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,11359,47,0.90 [0.56-1.46],0.681640691438417
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,11379,48,0.79 [0.45-1.39],0.4082819888790199
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,11388,50,0.85 [0.62-1.18],0.3460781437964709
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,11703,50,1.25 [0.99-1.57],0.0652854200602196
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,11655,49,1.14 [0.70-1.87],0.5920743234923858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,11296,47,0.96 [0.70-1.31],0.7745829912659704
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,13437,55,0.88 [0.39-2.00],0.7601268829696888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,11450,48,1.04 [0.54-1.99],0.913935398075561
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,11717,49,2.12 [0.70-6.46],0.1845957431773538
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PI3,Elafin,13334,56,0.79 [0.49-1.29],0.34664173512012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",11703,50,1.36 [0.98-1.87],0.0631468239718838
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,13355,55,1.39 [0.73-2.64],0.3114783779256412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,13509,56,1.00 [0.68-1.46],0.9946843736803392
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,13524,56,1.53 [0.61-3.84],0.3641446690157164
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,11388,50,1.09 [0.71-1.68],0.6870569932505957
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,13524,56,0.72 [0.41-1.26],0.2481730738487774
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,13523,54,0.89 [0.59-1.34],0.5797481423158224
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,11450,48,0.95 [0.63-1.43],0.8094332512291162
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,11273,47,0.76 [0.50-1.17],0.2190865803741241
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,11721,50,3.14 [1.11-8.89],0.0314066884556165
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,11359,47,1.22 [0.81-1.84],0.3504493671361625
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,13532,56,0.65 [0.45-0.95],0.0265818835829945
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,11468,50,0.94 [0.66-1.34],0.7345000420758022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,13437,55,0.79 [0.54-1.16],0.2283940617289743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,13554,56,1.14 [0.46-2.84],0.7801691450374058
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,13659,57,1.10 [0.62-1.93],0.7501980248589123
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",13481,55,0.47 [0.28-0.79],0.0042650122670756
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,13581,56,1.15 [0.88-1.50],0.2991429137722112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,13524,56,0.98 [0.45-2.10],0.9494369645275854
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,13634,56,1.06 [0.66-1.71],0.8017142649217682
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,13524,56,1.10 [0.50-2.41],0.8108992679942506
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,13428,55,1.35 [0.55-3.30],0.5062940704478688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",11685,50,1.00 [0.64-1.55],0.9913408606555476
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",11388,50,1.06 [0.62-1.80],0.8251789526135832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",11685,50,1.28 [0.97-1.70],0.0771921227969373
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,11685,50,1.47 [1.02-2.10],0.0384702071314688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,11405,46,0.96 [0.29-3.19],0.9507282396454364
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,13183,55,0.67 [0.31-1.44],0.3016025952691116
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,13523,54,1.22 [0.72-2.07],0.4685509572399046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,13523,54,1.14 [0.81-1.61],0.4565667572190813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,11672,50,1.62 [1.07-2.46],0.0239401033081143
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,13628,57,0.96 [0.49-1.88],0.9098191293291962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,13210,53,0.54 [0.23-1.27],0.157323415134917
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,11685,50,1.27 [0.50-3.21],0.6114852014580082
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,13509,56,1.22 [0.92-1.63],0.1686917238660775
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,13620,56,0.81 [0.29-2.26],0.6840007626478546
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,13481,54,1.45 [0.89-2.35],0.1330784502142289
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,13466,54,0.97 [0.85-1.10],0.6168414164007942
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,11359,47,1.22 [0.96-1.56],0.1034970421827447
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,11359,47,1.56 [1.02-2.38],0.0397079291182357
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,11379,48,1.11 [0.66-1.86],0.6941893140791755
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,13162,55,1.04 [0.84-1.30],0.7074299180502331
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,11717,49,1.16 [0.75-1.81],0.4984854082216921
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,11685,50,0.97 [0.68-1.39],0.8757093977383794
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,13519,56,0.99 [0.91-1.06],0.7067544210980656
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,11394,47,1.45 [0.93-2.28],0.1049380899828694
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,11376,48,0.73 [0.37-1.44],0.3584447379862204
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",13260,54,1.26 [1.08-1.46],0.0032843106984688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,13455,55,4.16 [0.91-19.14],0.066814512626241
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,13554,56,1.28 [0.54-3.03],0.5803951609056501
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,11388,50,0.87 [0.46-1.63],0.656553361123593
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,11388,50,1.22 [0.52-2.86],0.6530108065740439
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",13455,55,1.02 [0.51-2.04],0.9469405898978612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,11394,47,0.99 [0.66-1.51],0.9765624938923564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,11717,49,0.77 [0.29-2.00],0.5842016088378775
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,13293,54,0.84 [0.41-1.69],0.6210760994402242
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,13581,56,1.92 [0.71-5.20],0.1974415470849747
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,11700,50,1.29 [0.64-2.58],0.4768629579224529
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,11633,47,1.15 [0.83-1.59],0.3925880596949155
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,13653,57,1.11 [0.68-1.78],0.6824853134588442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,13509,55,1.09 [0.85-1.40],0.5007835283248658
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,11468,50,0.92 [0.57-1.47],0.7195091847199664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",11700,50,1.16 [0.77-1.73],0.4859454592683339
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,11388,50,1.49 [0.78-2.83],0.2264917275824041
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,13210,53,1.62 [0.92-2.84],0.092975019358279
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,11388,50,0.99 [0.65-1.51],0.97068450007199
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,11721,50,1.45 [0.88-2.39],0.1462694663477835
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,13455,55,0.89 [0.61-1.31],0.567364203923768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,11639,49,1.42 [1.04-1.93],0.0257090627310631
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,13554,56,1.14 [0.89-1.45],0.2946242201461113
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,11468,50,1.21 [0.91-1.61],0.1959681533994566
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,11703,50,1.10 [0.79-1.53],0.5829560959465773
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,11703,50,1.00 [0.49-2.07],0.9909185935603686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,13523,54,1.15 [0.86-1.54],0.3503024435908288
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,13680,57,1.16 [0.91-1.48],0.2290965002053426
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,11655,49,1.15 [0.92-1.44],0.2095806739358261
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,13437,55,1.23 [0.71-2.13],0.469088633552062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,11379,48,1.20 [0.92-1.56],0.1825693354158619
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,13498,55,0.94 [0.74-1.20],0.628318836771449
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,13210,53,0.67 [0.39-1.16],0.1506337341980148
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,11296,47,1.00 [0.34-2.94],0.9988481184699046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,11700,50,0.87 [0.47-1.64],0.6746443682193444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,11639,49,0.82 [0.40-1.68],0.5887663478743204
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,13595,57,0.96 [0.45-2.04],0.9183916455237664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,13155,54,1.24 [0.97-1.58],0.0883373684620888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,11517,48,0.70 [0.44-1.11],0.1302380469353742
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",13260,54,1.43 [1.05-1.94],0.0218490843137642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",13680,57,1.09 [0.78-1.53],0.6201194168531112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,13646,56,0.93 [0.63-1.38],0.7300053439694834
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,13260,54,0.95 [0.42-2.16],0.9107758512576632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,13519,56,1.20 [0.41-3.53],0.7453519675323088
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,11700,50,0.91 [0.54-1.53],0.7261611188428617
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,11700,50,1.05 [0.62-1.78],0.8471748777245701
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,13260,54,1.05 [0.69-1.61],0.8224511610110025
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,11379,48,1.42 [0.67-2.99],0.3608514563814992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,13523,54,1.14 [0.86-1.51],0.3747491048348318
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,11665,50,1.26 [0.92-1.73],0.1512265281810783
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,13260,54,1.27 [0.80-2.00],0.3093527105907551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,11359,47,1.23 [0.77-1.96],0.3885596900372234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,11450,48,1.24 [1.00-1.54],0.0536217349261924
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,13210,53,1.02 [0.70-1.47],0.9219560536049464
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,13653,57,0.95 [0.70-1.28],0.7209112058405942
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,11685,50,1.06 [0.64-1.76],0.8110692747976774
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,13515,56,1.64 [0.65-4.11],0.2936791204431336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,11359,47,1.21 [0.65-2.27],0.5442757747132854
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,13509,56,1.01 [0.73-1.40],0.9547654811439146
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,11728,48,1.47 [0.53-4.09],0.4636999726443767
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,11379,47,0.78 [0.51-1.19],0.246534848712904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,11388,50,1.07 [0.62-1.86],0.809542774475444
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,11394,47,2.00 [0.97-4.13],0.0618205191192634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,13533,56,1.13 [0.72-1.79],0.5875514215805855
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,11388,50,1.14 [0.54-2.42],0.7289436535892151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,13472,53,0.88 [0.49-1.61],0.6863712401733904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,11685,50,1.12 [0.56-2.25],0.746793256263232
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,13460,55,1.17 [0.65-2.10],0.5961908344089593
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,13183,55,1.11 [0.89-1.38],0.3731813371691285
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,13646,56,1.11 [0.44-2.83],0.8260448591570698
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,13161,51,0.90 [0.52-1.56],0.7113961392668442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,11468,50,0.90 [0.34-2.40],0.8345780779522737
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,11593,50,1.73 [0.84-3.57],0.1348226850280283
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,11655,49,1.11 [0.65-1.89],0.7097830142805329
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,11655,49,1.01 [0.91-1.12],0.8814555017635887
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,13437,55,0.95 [0.78-1.17],0.6332274005339966
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,13509,56,0.86 [0.57-1.29],0.4723478445693136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,13210,53,0.79 [0.45-1.39],0.4066923147190799
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,11296,47,1.75 [0.78-3.91],0.1752233245406592
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,11703,50,1.29 [0.79-2.10],0.3044146540759899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,11379,48,0.93 [0.56-1.54],0.7680758729103848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,13455,55,0.78 [0.50-1.22],0.2798541992427986
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,13419,55,1.03 [0.55-1.93],0.9263390380056546
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,13372,55,1.01 [0.53-1.90],0.9829800200230928
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,13509,56,0.88 [0.56-1.39],0.5750882272307329
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,11388,50,0.73 [0.44-1.22],0.2283918243647995
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,13509,56,0.99 [0.78-1.24],0.9167799287472764
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,13210,53,1.27 [0.87-1.84],0.210113500146513
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,11013,45,1.26 [0.95-1.68],0.1143481626712367
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",13183,55,1.22 [0.56-2.67],0.6127584590413747
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,13383,55,1.29 [0.57-2.93],0.543611633938154
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,11301,50,1.37 [0.85-2.18],0.1919288491081205
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,11721,50,1.24 [0.90-1.72],0.1894018586568945
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,11379,48,0.98 [0.69-1.40],0.9306288289357
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,13509,56,0.96 [0.51-1.83],0.9105950559269076
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,13183,55,1.49 [0.83-2.67],0.1867238497666941
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,13293,54,1.13 [0.70-1.81],0.6210469248414087
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,11388,50,1.14 [0.71-1.82],0.5950068922001609
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,13437,55,1.18 [0.88-1.58],0.2597303500475566
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,13560,56,1.21 [0.91-1.61],0.1823549726882694
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,11362,50,1.01 [0.51-2.00],0.9663824395042944
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,11721,50,0.84 [0.34-2.09],0.7039987386882403
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,11700,50,1.27 [0.40-4.01],0.6886441465265157
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,13685,57,1.05 [0.47-2.36],0.910505398549673
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,11655,49,1.16 [0.67-2.02],0.5932356749804735
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,11655,49,0.87 [0.25-2.97],0.8190125067460726
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,13483,56,1.01 [0.38-2.65],0.9861729365521676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,13385,55,1.77 [0.83-3.80],0.140647313057263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,11685,50,1.51 [0.76-3.01],0.2382312407362574
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,13685,57,1.16 [0.45-3.01],0.7561904335004177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,11721,50,1.35 [0.60-3.05],0.4714441829792889
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,11450,48,1.34 [0.86-2.11],0.1975706920678737
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,13127,54,0.80 [0.50-1.27],0.3416417348245766
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,11468,50,0.84 [0.43-1.66],0.6184026480953669
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,13509,56,1.16 [0.71-1.90],0.5406734713907788
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,13590,56,1.13 [0.91-1.40],0.2577203489260631
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,13653,57,1.22 [0.67-2.25],0.5148019498401936
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,11639,49,0.84 [0.49-1.46],0.5477167628500307
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,13183,55,0.66 [0.40-1.10],0.1093586449469358
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,11394,47,0.94 [0.48-1.82],0.8503887677939763
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,11359,47,0.91 [0.67-1.24],0.5559774702396083
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,11728,48,1.21 [0.83-1.77],0.3136701022555522
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,13466,54,1.14 [0.67-1.95],0.635661845786716
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,13525,56,1.11 [0.46-2.69],0.8122756473158712
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,11478,47,1.15 [0.70-1.87],0.5783907852716625
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,11721,50,1.85 [1.19-2.87],0.0061444543470475
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,11721,50,1.26 [0.98-1.63],0.0717285755170431
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,11721,50,1.34 [0.94-1.91],0.1055607158609996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,11639,49,1.20 [0.79-1.84],0.3966447086395388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,11359,47,1.34 [0.91-1.96],0.1385976236564186
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,13260,54,1.36 [1.11-1.68],0.0037779826872776
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,11359,47,1.01 [0.75-1.35],0.9407443011848676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,11376,48,1.15 [0.78-1.69],0.4912857711695467
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,11639,49,0.92 [0.48-1.74],0.788904220893945
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,13509,56,1.29 [0.83-2.01],0.2561015945907557
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,13183,55,1.66 [1.20-2.30],0.0022881228847965
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,11450,48,1.21 [0.86-1.71],0.2801428903412075
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,13210,53,1.36 [1.00-1.85],0.0513768944432215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,13260,54,0.99 [0.66-1.47],0.956105806628136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,11379,48,1.11 [0.79-1.56],0.5512298313358637
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,13210,53,1.16 [0.71-1.89],0.5590796799824111
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,11468,50,0.79 [0.43-1.42],0.4269361482205489
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,11388,50,1.99 [0.92-4.29],0.0807415567576758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,11639,49,0.82 [0.45-1.50],0.5114684383358004
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,11394,47,1.20 [0.72-2.00],0.4930695305581362
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,11376,48,1.37 [0.66-2.85],0.394478998366355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,13210,53,1.21 [0.82-1.79],0.3411690381290951
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,11388,50,0.56 [0.31-1.00],0.0498588150261829
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,11468,50,1.36 [0.87-2.12],0.1746176971851856
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,13210,53,1.13 [0.60-2.12],0.6955617232154541
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,13562,56,1.36 [0.86-2.15],0.1847487118989858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,13183,55,0.76 [0.36-1.60],0.4691427732856706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,11296,47,0.85 [0.43-1.67],0.6384455126315443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,13210,53,0.93 [0.60-1.45],0.7480696287606274
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,11703,50,0.81 [0.37-1.78],0.5991926044397151
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,13198,54,0.80 [0.50-1.31],0.3779005258265889
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,11703,50,1.26 [0.91-1.75],0.1708499304773428
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,11359,47,0.82 [0.43-1.58],0.5546685791543866
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,11296,47,0.90 [0.48-1.68],0.7426496514754475
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,11379,48,0.98 [0.66-1.45],0.9210087863299656
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,13455,55,1.03 [0.76-1.41],0.8478027380587869
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,13455,55,0.88 [0.56-1.38],0.5760634466598001
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,11655,49,0.94 [0.60-1.48],0.7936987824822171
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,11388,50,0.88 [0.55-1.40],0.5940126750109249
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,11394,47,1.25 [0.97-1.62],0.0895327937541772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,11639,49,1.00 [0.59-1.68],0.9888802211379336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,13293,54,0.91 [0.51-1.61],0.7368407111589089
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,11394,47,2.77 [0.79-9.66],0.1097277484403028
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,11703,50,1.34 [0.92-1.94],0.1225166537983796
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,13418,56,0.90 [0.53-1.51],0.6823869879042816
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,13685,57,0.69 [0.43-1.12],0.1309824574299183
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,13685,57,0.89 [0.59-1.34],0.5719945012052668
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,11639,49,0.57 [0.28-1.20],0.1394589345197313
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,13544,56,1.11 [0.67-1.84],0.6820379696548984
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,11388,50,1.17 [0.74-1.83],0.5022673713788078
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,13524,56,1.19 [0.47-2.97],0.7122281025952157
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REN,Renin,13523,54,1.10 [0.77-1.58],0.6088806340094781
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,11388,50,1.86 [1.15-3.03],0.0119879551772841
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,11296,47,1.17 [0.61-2.26],0.6404908155623499
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,13455,55,1.21 [0.69-2.13],0.4995533512638814
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RETN,Resistin,13464,55,1.07 [0.60-1.92],0.8124120583765758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",11359,47,0.99 [0.57-1.72],0.9716719886700677
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,11639,49,0.97 [0.27-3.47],0.9624927330692532
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,11703,50,1.47 [1.05-2.07],0.0267851461368583
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,11468,50,1.26 [0.93-1.72],0.1352782116835263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,13653,57,1.14 [0.53-2.45],0.7274898605386524
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,13653,57,1.46 [0.58-3.72],0.4244044418597201
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,11703,50,1.35 [0.91-2.01],0.1338310604598475
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,13260,54,0.88 [0.58-1.33],0.5430690996194508
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,13340,55,1.08 [0.88-1.33],0.4748945601568746
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,11388,50,1.06 [0.63-1.80],0.8222662559307335
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,11450,48,0.80 [0.44-1.45],0.4692358722948271
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,13609,56,0.99 [0.67-1.46],0.957377302092903
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,11721,50,1.38 [1.04-1.83],0.025950797382344
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,11359,47,1.23 [0.89-1.69],0.2127910435205417
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,11703,50,0.95 [0.70-1.29],0.7523355067852442
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,11434,48,0.89 [0.72-1.10],0.2715019137242316
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,11717,49,1.43 [0.45-4.50],0.5453841282448131
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,11394,47,1.26 [0.77-2.06],0.3531803366224959
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,13454,53,0.84 [0.66-1.06],0.1440912145955343
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,11320,47,2.28 [1.07-4.89],0.0333019386140034
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,11624,48,1.13 [0.43-2.98],0.8122741241655519
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,11703,50,1.00 [0.59-1.69],0.9898154867264788
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,13617,57,1.66 [0.72-3.81],0.2312238504407577
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,11394,47,2.39 [1.01-5.67],0.0481545025846389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,11388,50,1.07 [0.58-1.99],0.8275406233128891
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,11388,50,1.91 [1.32-2.77],0.0005766531506185
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,11468,50,1.11 [0.76-1.62],0.5928237124894675
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,13210,53,1.06 [0.74-1.50],0.7614703394704354
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,11468,50,1.00 [0.64-1.57],0.9990189563135016
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,11394,47,1.38 [0.92-2.07],0.1178972535120653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,13544,56,0.99 [0.37-2.70],0.991579310737998
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,13653,57,2.13 [0.79-5.74],0.1357848617984011
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,11394,47,3.78 [0.79-18.11],0.0956881789213576
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,13523,54,1.44 [0.66-3.16],0.3561919948603198
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,13455,55,1.69 [1.07-2.65],0.0241019149002086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,11388,50,1.06 [0.46-2.43],0.8997613415239647
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,11468,50,1.26 [0.90-1.76],0.1836698958569295
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,11379,48,1.35 [0.79-2.30],0.2774774135208321
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,11394,47,1.17 [0.65-2.11],0.605335226153926
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,11359,47,1.08 [0.59-1.98],0.801645893459769
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,11379,48,1.23 [1.01-1.50],0.0427748140736604
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,13210,53,0.74 [0.42-1.33],0.3195043359887177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,13210,53,1.00 [0.70-1.44],0.980856492822672
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,11376,48,0.91 [0.67-1.24],0.5584480800573581
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,13437,55,1.53 [0.81-2.90],0.1927789905252069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,13646,56,1.80 [0.81-4.02],0.1482906678883327
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,13455,55,1.48 [0.66-3.36],0.343507940085945
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,11359,47,0.97 [0.57-1.65],0.9191987861328218
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",11703,50,1.39 [1.04-1.85],0.0243911968249848
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,13646,56,0.91 [0.44-1.86],0.7881754587486152
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,13210,53,0.99 [0.78-1.25],0.9238949988647768
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,13653,57,1.12 [0.78-1.61],0.5294197056235637
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,11359,47,0.85 [0.35-2.09],0.7269089070330721
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,13409,53,0.70 [0.38-1.30],0.2575351989214097
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,13339,55,0.95 [0.70-1.31],0.7708324012420235
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,11388,50,0.97 [0.44-2.17],0.9463285765308648
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,11703,50,1.11 [0.68-1.82],0.6794887480951454
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,13164,55,0.76 [0.51-1.14],0.1865929277809634
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,11639,49,1.12 [0.67-1.88],0.6717879069019851
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,13554,56,0.98 [0.65-1.48],0.9292327298615388
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,11703,50,0.97 [0.53-1.80],0.9289169453799212
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,13293,54,1.04 [0.68-1.60],0.8507256387816439
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,11728,48,1.16 [0.60-2.23],0.66133921164793
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,11703,50,1.12 [0.44-2.85],0.8142015478593008
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,11376,48,0.85 [0.49-1.49],0.5723070060449487
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,13509,56,1.16 [0.85-1.58],0.3571206202650251
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,11468,50,0.93 [0.63-1.37],0.7159077369098912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,11681,50,1.24 [0.96-1.59],0.1008872489081158
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,11359,47,1.14 [0.59-2.20],0.70555352046352
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,11359,47,1.53 [1.07-2.20],0.0210815948655824
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,11468,50,1.02 [0.70-1.48],0.9308418623715176
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,11703,50,0.94 [0.40-2.20],0.8841971258067522
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,11676,50,1.03 [0.46-2.31],0.93506214416032
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,13455,55,1.22 [0.93-1.60],0.1501331328211012
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,13653,57,0.99 [0.44-2.23],0.9715889581415822
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,13183,55,0.72 [0.42-1.24],0.2346145475618833
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,13184,55,1.21 [0.51-2.86],0.6584537130813772
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,13685,57,1.34 [0.79-2.27],0.2802702356326642
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,13653,57,1.75 [0.76-3.99],0.1858485899979814
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,13584,56,1.01 [0.47-2.17],0.9827586225117048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,13544,56,1.32 [0.64-2.71],0.4511492990411172
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,13545,56,1.00 [0.66-1.50],0.9853782906272144
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,11359,47,0.89 [0.35-2.25],0.8002470810789062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,11450,48,0.74 [0.24-2.30],0.6021130999219528
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,13560,56,1.01 [0.76-1.34],0.9720367726078112
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,13260,54,1.14 [0.66-1.95],0.6372462827263328
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,11376,48,1.00 [0.69-1.46],0.987349946767465
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,13609,56,0.81 [0.49-1.34],0.4182427237750485
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,11376,48,1.02 [0.59-1.78],0.9352634745596904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,11379,48,1.94 [1.09-3.44],0.0240147010817525
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,11379,48,1.35 [0.82-2.20],0.2342064855860037
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,11376,48,0.91 [0.48-1.73],0.773152753684673
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,11394,47,0.87 [0.44-1.73],0.6943953142795865
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,13210,53,1.38 [1.11-1.72],0.003613036151952
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,11352,47,1.63 [0.98-2.72],0.061994510604529
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,11721,50,1.30 [0.48-3.50],0.6093889206766072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,11394,47,1.15 [0.89-1.48],0.2957428880894087
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,13509,56,1.25 [0.85-1.83],0.2576997914509595
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SCT,Secretin,11379,48,0.78 [0.41-1.50],0.4587855032937291
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,13523,54,1.38 [0.81-2.37],0.2408844122412136
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,13523,54,1.48 [0.86-2.54],0.1541810246638351
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,11639,49,1.19 [0.94-1.51],0.1531204715200728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,11655,49,1.20 [0.86-1.67],0.2774325352436197
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,11450,48,1.41 [0.71-2.78],0.3269132359096753
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,11394,47,1.55 [1.05-2.28],0.0262959524533113
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,11394,47,1.50 [0.85-2.66],0.1628464274960722
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,13685,57,0.98 [0.62-1.56],0.9400336282268758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,11728,48,1.06 [0.31-3.59],0.9310333324925892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,11728,48,1.21 [0.37-3.97],0.7537754446797478
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,13533,56,1.21 [0.82-1.79],0.3436642397294411
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,13509,56,1.23 [0.53-2.89],0.6293768151074278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,13523,54,0.84 [0.32-2.16],0.7124175968007647
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,11450,48,0.85 [0.44-1.61],0.6100593791345468
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,13455,55,0.95 [0.40-2.22],0.8974747726652463
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,13653,57,1.76 [0.80-3.84],0.157422930368917
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,11388,50,1.55 [0.69-3.49],0.2908215711025284
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,13634,56,0.74 [0.29-1.90],0.5337877532493296
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,11703,50,0.98 [0.68-1.41],0.912982157488518
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,11468,50,0.92 [0.53-1.59],0.7552230882953186
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,11657,50,1.21 [0.55-2.65],0.6347577634044517
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,13455,55,1.39 [0.65-2.98],0.3900594544029955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,11499,46,0.43 [0.07-2.79],0.3734117889452124
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,13685,57,0.99 [0.56-1.76],0.976185965939594
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,13161,53,0.77 [0.59-1.00],0.0503259731274688
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,11688,48,1.02 [0.15-6.79],0.9823232589433952
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,11499,47,2.10 [0.67-6.56],0.2011636096029853
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,11543,47,0.87 [0.36-2.07],0.7474825968959651
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,11728,48,0.69 [0.15-3.13],0.6257510660773062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,11728,48,2.00 [0.49-8.17],0.3322351809395364
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,13375,55,0.55 [0.40-0.75],0.0001507019737653
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,13481,55,1.16 [0.90-1.50],0.2407705226725598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,13293,54,1.21 [0.74-1.99],0.4453994480677502
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,13611,57,1.27 [0.87-1.84],0.2202761708109467
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,13680,57,0.71 [0.45-1.14],0.1623222844112227
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,13437,55,1.33 [0.68-2.63],0.4071786690300477
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,11701,48,1.59 [0.25-10.18],0.6221277612687276
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,11701,48,1.89 [0.71-4.98],0.2006145872412817
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,13685,57,1.16 [0.82-1.63],0.4004129514319834
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,11721,50,1.48 [1.00-2.20],0.0504650430023219
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,11553,47,1.27 [0.44-3.66],0.6539799153478036
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,11501,46,2.19 [0.30-15.83],0.4360429916451052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,11701,48,1.24 [0.29-5.31],0.774728484264284
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,11468,50,1.21 [0.98-1.50],0.0708805053798992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,11421,48,0.50 [0.19-1.32],0.1618879794422477
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,11655,49,1.09 [0.68-1.73],0.7226752101430968
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,13183,55,1.27 [0.90-1.80],0.1799396076539969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,13400,54,0.75 [0.32-1.74],0.4992832066219604
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,11379,48,1.87 [0.94-3.70],0.0735526729230496
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,13554,56,1.47 [0.61-3.52],0.385364979619119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,13455,55,2.94 [1.21-7.14],0.0174961670920324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,13455,55,1.00 [0.73-1.37],0.9825026238031802
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,13392,54,1.55 [0.92-2.60],0.100307220506583
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,11450,48,0.66 [0.35-1.26],0.2065169757313975
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,13210,53,1.15 [0.80-1.66],0.4527235131884128
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,13210,53,1.10 [0.69-1.75],0.68404127364804
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,13523,54,0.70 [0.49-1.01],0.0597758676498759
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,11527,48,0.93 [0.55-1.55],0.771628718776425
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,13210,53,1.10 [0.85-1.41],0.4690514899827839
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,13509,56,1.05 [0.70-1.57],0.8292755368050858
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,11376,48,1.00 [0.64-1.56],0.9875168894085108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,11655,49,1.00 [0.58-1.72],0.9969754517075996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,11407,50,0.97 [0.71-1.34],0.8748652302245299
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,11685,50,1.12 [0.76-1.67],0.5686617370468312
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,11717,49,1.34 [0.81-2.23],0.2588668092180253
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,11296,47,1.17 [0.94-1.45],0.1661094343376495
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,11339,47,0.62 [0.37-1.03],0.0658659319079343
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,11388,50,1.43 [0.85-2.40],0.1780824897572609
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,11700,50,1.83 [0.65-5.11],0.2491228428331903
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",13560,56,1.13 [0.87-1.47],0.3669285983282473
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,11468,50,1.15 [0.65-2.05],0.633645410915674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,13531,56,1.49 [0.93-2.41],0.1000968343769366
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,13581,56,0.58 [0.34-0.99],0.0447229941276321
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,13509,56,1.20 [0.58-2.49],0.6199739901443546
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,13183,55,0.86 [0.61-1.20],0.3745868066857686
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,13524,56,0.99 [0.81-1.20],0.8922053728816323
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,13646,56,1.23 [0.61-2.50],0.5583389942463675
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,13523,54,1.07 [0.46-2.48],0.8829741622986798
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,11394,47,1.07 [0.58-1.96],0.8324129110331744
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,13630,56,1.01 [0.46-2.23],0.9720690919876216
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,11394,47,1.51 [0.85-2.68],0.1555521756061494
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,13543,56,1.04 [0.69-1.59],0.8395868073905606
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,13491,56,0.74 [0.43-1.27],0.2730006456492769
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,11388,50,1.03 [0.78-1.38],0.8181504261421464
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,13455,55,1.10 [0.85-1.44],0.4682201842633722
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",13183,55,1.05 [0.70-1.57],0.8094638902238377
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,13260,54,1.09 [0.71-1.67],0.6946663124431413
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,13408,55,0.91 [0.66-1.27],0.5826318089067546
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,13581,56,1.10 [0.88-1.38],0.3928841401179341
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,11359,47,0.95 [0.48-1.86],0.8701297237339175
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,11703,50,1.30 [1.00-1.68],0.0459903108816926
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,13260,54,0.79 [0.54-1.15],0.220764259325387
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,13210,53,1.05 [0.55-2.00],0.8833807909468055
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,13509,56,0.75 [0.49-1.14],0.1766876827835368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,13210,53,0.86 [0.54-1.36],0.5184859762071086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,11359,47,1.59 [0.96-2.65],0.0725452420859019
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,11639,49,1.20 [0.87-1.66],0.2670155311798363
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,13183,55,1.43 [1.09-1.90],0.0112260373901034
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,11379,48,1.55 [1.11-2.17],0.0111091334828911
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,13183,55,1.23 [0.93-1.61],0.1472826135352778
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,11296,47,0.69 [0.39-1.24],0.2131594831639598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,11296,47,1.14 [0.68-1.90],0.6150745211455035
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,13183,55,0.99 [0.47-2.08],0.9742024880143544
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,13509,56,1.06 [0.70-1.60],0.7707681386400832
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,11379,48,1.23 [0.91-1.67],0.1809604459877134
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,11700,50,0.65 [0.36-1.17],0.1548651653583599
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,11359,47,0.88 [0.60-1.29],0.5243085025953522
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,11450,48,1.35 [0.98-1.85],0.0685590136080523
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,11655,49,1.11 [0.71-1.74],0.6484076341452546
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",11296,47,1.47 [1.06-2.06],0.0228036436986443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,13183,55,0.95 [0.59-1.51],0.8160302741179888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,11388,50,2.29 [1.05-4.97],0.0363929644566279
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,13646,56,1.39 [0.75-2.58],0.2945823664894823
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,13293,54,1.11 [0.55-2.23],0.764521577688013
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,11468,50,0.67 [0.40-1.11],0.1183460280475176
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,11655,49,1.30 [0.96-1.77],0.0866864761907225
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,11612,50,0.55 [0.23-1.31],0.177669531057198
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,13210,53,1.09 [0.81-1.47],0.567727833211872
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,11639,49,1.25 [0.86-1.82],0.2491708415286192
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,11639,49,1.16 [0.68-1.96],0.5907408003810899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,13455,55,2.29 [0.69-7.63],0.1756605359095618
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,13183,55,1.27 [0.96-1.68],0.0998936446209837
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,11296,47,0.97 [0.57-1.63],0.9005556650967147
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,11655,49,0.92 [0.58-1.46],0.7082623790429365
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,13646,56,1.06 [0.52-2.14],0.8799689596248361
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,13581,56,0.98 [0.53-1.82],0.9510405445232956
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,13587,57,0.69 [0.42-1.14],0.1480460618371251
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,11388,50,0.96 [0.61-1.53],0.8760127618580811
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,13553,56,0.95 [0.67-1.37],0.7992096887808959
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,11639,49,0.85 [0.55-1.30],0.4527887426618372
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,11376,48,1.17 [0.80-1.71],0.424259285740643
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,11659,50,1.12 [0.87-1.45],0.3876965866319867
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,13523,54,1.13 [0.85-1.50],0.4032912459156527
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,11376,48,1.61 [0.93-2.81],0.091711621032821
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,13554,56,1.18 [0.91-1.53],0.2188619618543172
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,11703,50,1.30 [0.84-2.03],0.2398333873628169
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,11450,48,1.06 [0.83-1.35],0.6322488958948596
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,13437,55,0.92 [0.64-1.32],0.6434691074109135
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",11394,47,2.08 [1.10-3.93],0.0234849311752152
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',11685,50,1.10 [0.66-1.83],0.7091811208752383
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,11359,47,1.24 [0.88-1.73],0.2178372735408946
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,11450,48,1.20 [0.73-1.97],0.4679419187342503
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,11655,49,1.74 [1.16-2.61],0.0069947710874645
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,11639,49,1.04 [0.74-1.47],0.8103829993184083
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,11394,47,2.40 [1.20-4.79],0.0129702526240701
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,13523,54,1.16 [0.83-1.62],0.3910853417834624
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],13197,55,0.92 [0.56-1.49],0.7257290910704448
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",13524,56,1.28 [0.70-2.31],0.4215352838481629
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,11717,49,1.06 [0.70-1.60],0.7925804695057249
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,11703,50,0.67 [0.28-1.59],0.3618734439429782
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,13210,53,1.62 [0.81-3.27],0.1749341201608459
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,13583,56,0.66 [0.48-0.92],0.0135192905213936
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,13505,54,1.64 [0.87-3.10],0.1244420970882063
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,13505,54,0.82 [0.44-1.51],0.5189445284965228
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,11379,48,1.14 [0.70-1.84],0.6021722956616278
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,11689,50,1.02 [0.33-3.17],0.9689894774065758
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,11379,48,1.44 [0.52-3.96],0.4826026855429892
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,11703,50,1.51 [0.78-2.95],0.2235862236060203
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,11703,50,1.18 [0.78-1.77],0.4389178335923706
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,13554,56,1.02 [0.73-1.41],0.9195949468236722
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,13491,56,1.21 [0.52-2.82],0.6593035990511826
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPART,Spartin,11450,48,1.22 [0.87-1.72],0.2522534143742106
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,11721,50,1.44 [0.55-3.73],0.4570561486421922
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,13524,56,0.64 [0.35-1.19],0.1621630118038668
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,11450,48,1.28 [0.64-2.57],0.4913804326552511
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,13509,56,1.04 [0.72-1.51],0.8303143355063664
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,13524,56,1.10 [0.53-2.27],0.7929573404719625
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,13646,56,0.81 [0.53-1.23],0.3243301418198134
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,11359,47,1.17 [0.62-2.20],0.626058985856847
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,13479,55,1.06 [0.41-2.77],0.8974780203905938
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,13581,56,1.30 [0.74-2.30],0.3654224979585386
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,11655,49,1.03 [0.83-1.28],0.8009478548840953
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,13437,55,2.01 [0.79-5.11],0.1403982858747154
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,13544,56,1.30 [0.63-2.66],0.4820881661735369
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,13461,54,1.16 [0.57-2.36],0.6751420547249661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,13657,57,0.91 [0.56-1.49],0.7120562350174248
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",11388,50,1.17 [0.68-2.00],0.576886963370668
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,11296,47,0.80 [0.45-1.43],0.4497148307639905
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,11468,50,0.99 [0.73-1.36],0.962420568388504
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,11685,50,0.84 [0.57-1.25],0.3909415316562752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,13260,54,1.25 [0.97-1.59],0.0797729568552748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",11376,48,1.93 [1.09-3.42],0.0240452240157514
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,11685,50,1.28 [0.72-2.29],0.3976667844775511
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,13531,56,1.13 [0.93-1.38],0.2203572861012752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,13455,55,0.89 [0.60-1.32],0.5717740937651171
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,13509,56,1.11 [0.85-1.46],0.4309156129788797
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,11721,50,1.75 [0.76-3.98],0.1858481202616661
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,13183,55,1.21 [0.90-1.64],0.2028446503020445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",11388,50,0.81 [0.36-1.82],0.6059995662048471
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,13505,54,1.09 [0.87-1.37],0.4367320982142024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,13533,56,1.23 [0.71-2.14],0.4664269611145503
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,11296,47,1.66 [0.78-3.53],0.1841946527901724
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,11655,49,1.40 [0.86-2.28],0.1792095770224027
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,11450,48,1.18 [0.73-1.92],0.5064060085847986
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",13455,55,0.97 [0.56-1.69],0.9164653461278148
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",13685,57,0.83 [0.37-1.90],0.663942947647268
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",11388,50,0.87 [0.47-1.62],0.6624539264967728
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,11700,50,0.73 [0.29-1.84],0.5043870207976546
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,11639,49,1.42 [0.79-2.56],0.2405401390087955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,13408,55,1.11 [0.77-1.59],0.584605221823617
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,11388,50,1.29 [0.92-1.82],0.1347360185142636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,13455,55,1.03 [0.86-1.22],0.7793768592474086
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,11296,47,0.85 [0.53-1.36],0.4956311647167232
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,13653,57,0.93 [0.52-1.67],0.8084433466530152
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,13501,56,0.89 [0.38-2.07],0.7908203579312577
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,11376,48,0.88 [0.58-1.34],0.5606858373397348
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,13502,55,1.14 [0.80-1.63],0.454498465810045
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,13293,54,1.13 [0.81-1.56],0.4740014728011492
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,13183,55,1.08 [0.74-1.59],0.6924863028905219
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,13523,54,1.14 [0.87-1.50],0.3491081979031167
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",11296,47,1.03 [0.77-1.38],0.8483386786229797
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,13210,53,1.25 [0.87-1.80],0.2256509140499251
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,11379,48,1.08 [0.59-1.95],0.8105744983988445
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,11685,50,1.49 [0.94-2.39],0.0931091593446814
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,13455,55,1.22 [0.89-1.67],0.2250183613487462
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,11388,50,1.11 [0.62-2.01],0.7252292288843813
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,13210,53,1.01 [0.72-1.42],0.9624997146806028
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,11388,50,1.10 [0.65-1.87],0.7181939580382564
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,13509,56,1.42 [0.94-2.15],0.0975825799619263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,11703,50,1.34 [0.94-1.90],0.1008832494089093
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,13210,53,1.06 [0.61-1.83],0.8409509339354541
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,11655,49,1.42 [0.80-2.53],0.2269732022377491
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,13210,53,1.09 [0.80-1.47],0.5900476098951262
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,13653,57,1.09 [0.91-1.31],0.3503555130069833
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,13509,56,1.11 [0.74-1.67],0.5981389001425561
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,11388,50,0.85 [0.54-1.36],0.4994408189015944
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,13653,57,1.35 [0.86-2.11],0.192867200048011
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",11703,50,1.27 [0.86-1.85],0.2259662724423598
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,13293,54,1.13 [0.68-1.85],0.6411479305059566
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,13524,56,0.82 [0.36-1.88],0.6409796528650665
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,11639,49,1.52 [0.95-2.43],0.0813796286093912
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,11381,47,1.41 [0.62-3.22],0.4111836519614364
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,11379,48,1.23 [0.84-1.81],0.2833645206712982
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,11655,49,0.78 [0.35-1.75],0.5536677306394389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,11450,48,1.35 [0.85-2.14],0.2087771365237443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,11376,48,0.75 [0.42-1.34],0.3368497307166994
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,11685,50,1.45 [0.92-2.31],0.1116375033356581
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,11721,50,1.17 [0.83-1.66],0.3648957118887055
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,11468,50,1.23 [0.96-1.58],0.0967727844491349
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,13455,55,1.08 [0.88-1.32],0.4769058012660888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,11983,48,0.94 [0.39-2.27],0.8875923567817325
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,11639,49,1.59 [0.86-2.94],0.1360773998892789
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,13455,55,1.87 [0.96-3.64],0.0655496085477403
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,11296,47,1.04 [0.67-1.61],0.8705631348757176
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,11659,50,1.24 [0.71-2.18],0.4466966471992062
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,13260,54,1.18 [0.85-1.65],0.3283297327355691
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,11468,50,1.38 [1.06-1.80],0.0162010122158392
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,13183,55,1.09 [0.81-1.47],0.5872116823262228
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",11379,48,1.31 [1.02-1.69],0.0340848199894819
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",11639,49,2.11 [1.21-3.66],0.0083454566822159
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,11685,50,1.23 [0.83-1.81],0.3016872745032419
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,13183,55,1.00 [0.59-1.68],0.9883263993850048
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,13455,55,1.12 [0.87-1.45],0.3814943304578674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,13509,56,1.09 [0.82-1.44],0.5514306220762247
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,11450,48,1.20 [0.88-1.63],0.2457690637783978
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,13437,55,1.10 [0.87-1.40],0.4248724932053541
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,13437,55,1.10 [0.82-1.48],0.5071420579263857
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,13210,53,1.11 [0.83-1.48],0.4870086791056965
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,11379,48,1.25 [0.80-1.95],0.3230092505963516
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,13410,55,0.93 [0.72-1.21],0.60420385154519
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,13293,54,1.20 [0.97-1.48],0.0945332868151249
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,11476,47,1.51 [0.69-3.29],0.3046320554198241
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,13657,57,0.46 [0.20-1.05],0.0642961682710239
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,11721,50,0.90 [0.36-2.24],0.8189193968483336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,11468,50,1.11 [0.75-1.64],0.6151317491761424
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,11721,50,0.86 [0.34-2.17],0.7456055966343693
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,13183,55,1.23 [1.05-1.45],0.0127064554126177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",11379,48,1.19 [0.67-2.11],0.5480828580727078
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,11639,49,0.84 [0.54-1.31],0.4353963782250756
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,13183,55,1.14 [0.87-1.49],0.329355877548632
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,11359,47,1.07 [0.57-2.00],0.8448131366795177
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,13554,56,0.77 [0.26-2.33],0.6455579894891248
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,11388,50,1.19 [0.49-2.89],0.6989118085696562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,11452,50,0.87 [0.63-1.21],0.4067792909356448
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,11379,48,1.39 [0.72-2.70],0.3249766526861304
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,11468,50,0.99 [0.50-1.93],0.9659229033258324
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,11728,48,0.98 [0.29-3.32],0.9745154636087562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,11376,48,0.89 [0.53-1.47],0.6359621406443299
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,13457,56,1.06 [0.77-1.45],0.7188862556478024
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,13560,56,1.15 [0.77-1.71],0.4847261859437902
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,13479,56,1.08 [0.74-1.60],0.6802902419241947
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,13443,55,1.38 [0.71-2.67],0.340159912346766
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,13503,55,0.81 [0.41-1.62],0.5543066485175532
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,13546,56,1.44 [0.84-2.46],0.1799292928935662
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,11639,49,1.01 [0.79-1.28],0.950132669564854
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,13509,56,1.02 [0.62-1.69],0.926062580131938
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,13653,57,1.05 [0.57-1.92],0.8763727218652394
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,11639,49,1.27 [0.82-1.96],0.2783249429671716
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,13404,55,0.73 [0.30-1.77],0.4927440218816834
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,11388,50,1.36 [0.44-4.17],0.5954185514863692
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,13554,56,1.42 [0.65-3.12],0.3826818973634556
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,13685,57,0.88 [0.45-1.74],0.7141002730558272
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,13502,54,0.81 [0.59-1.10],0.1733286050084552
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,11717,49,1.68 [0.56-4.99],0.3516126017315005
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,11273,47,0.70 [0.46-1.07],0.1018583537743975
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,13523,54,1.34 [0.55-3.24],0.5220042523045161
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,13524,56,0.68 [0.34-1.38],0.28722097372098
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,13494,56,0.85 [0.51-1.44],0.548289065783774
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,13473,54,0.39 [0.17-0.91],0.0293484651554059
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,13293,54,1.43 [0.76-2.66],0.2658398711264179
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,11359,47,0.98 [0.77-1.24],0.8392009687428594
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,11306,50,1.37 [0.68-2.76],0.3784681086918631
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,11623,49,1.19 [0.88-1.62],0.2569743039648328
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,13653,57,1.38 [0.58-3.29],0.470711412595638
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,13152,54,1.08 [0.88-1.31],0.4590254730543138
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,13685,57,0.80 [0.49-1.31],0.3714828023996916
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",13154,55,1.02 [0.62-1.68],0.92267467526399
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,11468,50,0.60 [0.25-1.39],0.2302911244991904
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,13533,56,0.85 [0.50-1.45],0.5472601164494092
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,11721,50,1.84 [1.02-3.31],0.0411437700403207
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,11685,50,1.33 [0.98-1.80],0.0654642050347401
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,13324,54,0.72 [0.29-1.77],0.4689764183788415
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,11721,50,1.49 [0.71-3.15],0.2914888733442419
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,13581,56,1.12 [0.95-1.32],0.1917985918056786
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,13524,56,1.52 [0.88-2.61],0.1318066156003901
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,13478,54,1.12 [0.38-3.32],0.83115309561295
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,13554,56,1.19 [0.90-1.58],0.2229299796529036
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,11376,48,1.13 [0.65-1.96],0.6731493376334101
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",11468,50,0.81 [0.42-1.60],0.5487111630827722
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,11388,50,1.62 [0.62-4.23],0.3206947413239228
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,11468,50,2.92 [1.04-8.20],0.0417265358629458
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,13680,57,0.76 [0.53-1.07],0.1184163715123114
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,11388,50,0.95 [0.36-2.52],0.9216443957595992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,11379,48,1.32 [0.85-2.06],0.2213681148656389
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,11468,50,0.78 [0.45-1.36],0.3885378754854414
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,11359,47,1.09 [0.68-1.73],0.72713357126254
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,11359,47,1.25 [0.85-1.83],0.2526293528864264
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,11655,49,1.36 [1.04-1.79],0.0262743754402995
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,11639,49,1.15 [0.80-1.65],0.4546044135365263
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,11394,47,1.48 [1.03-2.13],0.0333651530591336
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,11703,50,1.03 [0.56-1.89],0.9205816329792876
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,11296,47,0.91 [0.45-1.81],0.7819313200157301
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,11376,48,1.02 [0.72-1.45],0.9028466632479366
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,11657,50,0.67 [0.32-1.41],0.2931292768894106
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,13455,55,0.95 [0.73-1.23],0.6928851095831248
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,13368,54,1.71 [0.89-3.27],0.1069490219833743
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,13524,56,1.11 [0.82-1.50],0.4970872320387519
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,13533,56,0.90 [0.54-1.49],0.6796859847342707
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,13273,54,0.61 [0.28-1.31],0.2057886234542069
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,11655,49,1.35 [0.83-2.17],0.2233068677745003
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,13260,54,1.01 [0.52-1.98],0.9675765597339512
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,11450,48,1.34 [0.90-2.00],0.147867651628719
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,13437,55,0.82 [0.38-1.78],0.6154461430234937
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,13437,55,1.04 [0.60-1.82],0.8833826096842557
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,13530,56,1.15 [0.71-1.86],0.5732684301335502
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,13680,57,0.91 [0.47-1.75],0.7679120999141823
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,13519,56,0.48 [0.21-1.10],0.0826839278239549
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,13554,56,0.92 [0.45-1.88],0.8212594763856612
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,13544,56,0.95 [0.43-2.08],0.895728934822597
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,13260,54,1.26 [0.70-2.28],0.4424237137998665
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,13544,56,1.80 [0.83-3.90],0.1345572761846193
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,11450,48,1.42 [0.69-2.91],0.3379592288292044
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,13646,56,1.44 [0.65-3.20],0.3664183240087409
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,13524,56,1.01 [0.42-2.42],0.9873004832784984
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,13524,56,0.83 [0.40-1.73],0.6115106792275876
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,13653,57,1.16 [0.49-2.77],0.7375465249421558
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,13653,57,0.74 [0.37-1.44],0.3728303139473961
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,13437,55,1.30 [0.86-1.96],0.2109334372629992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,13653,57,0.90 [0.53-1.54],0.6967994385286371
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,13437,55,0.93 [0.48-1.78],0.8203786581684769
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,13680,57,0.78 [0.32-1.86],0.5693839609107254
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,13509,56,0.93 [0.64-1.36],0.7111828721342838
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,13680,57,0.81 [0.37-1.77],0.595444335505019
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,13581,56,1.38 [0.57-3.35],0.4735754931748603
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,13654,56,0.78 [0.31-1.98],0.6076039854647259
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,13437,55,1.25 [0.84-1.87],0.2691850582589577
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,11700,50,0.73 [0.34-1.58],0.4297008131658618
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,11685,50,1.28 [0.96-1.70],0.0953755392911862
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,11700,50,0.98 [0.53-1.79],0.9386334938627569
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",13293,54,0.90 [0.70-1.17],0.4438547300230244
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,11468,50,1.22 [0.60-2.47],0.5904266614463003
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,13437,55,1.26 [0.72-2.21],0.4185605585350502
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,13524,56,0.99 [0.40-2.45],0.9752223199879227
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,11721,50,1.36 [0.98-1.89],0.062375721254356
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,11655,49,0.95 [0.74-1.22],0.6961243740303412
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",11296,47,0.76 [0.40-1.46],0.4112469929564529
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,11388,50,1.41 [1.03-1.93],0.0336598864613659
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,11394,47,1.18 [0.74-1.87],0.4918506874177447
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,13210,53,1.25 [0.73-2.15],0.41829576938483
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,11388,50,0.86 [0.62-1.18],0.3467202800644583
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,11191,46,1.03 [0.61-1.75],0.9106722613443676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,13293,54,1.01 [0.48-2.11],0.9816401310474178
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,11379,48,1.04 [0.47-2.29],0.9279389804979684
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,11379,48,0.89 [0.45-1.78],0.7504913016826424
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,11450,48,1.26 [0.96-1.64],0.0905533142148996
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,11721,50,1.59 [0.62-4.08],0.3377554882534371
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,11359,47,1.42 [0.89-2.26],0.144668509859405
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,13210,53,0.76 [0.53-1.07],0.1138139228362161
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,13438,55,0.86 [0.50-1.49],0.5875156957456137
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,11468,50,0.84 [0.59-1.21],0.3480866422047355
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,13183,55,0.78 [0.40-1.52],0.458927619152101
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,11359,47,0.86 [0.46-1.61],0.6434383076811656
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,11296,47,0.94 [0.60-1.49],0.8062002445653659
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,13656,57,0.75 [0.49-1.15],0.1920144400178333
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,11703,50,1.28 [0.72-2.26],0.4026671818154899
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,11388,50,1.83 [0.93-3.59],0.0782181002053835
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,13260,54,1.12 [0.82-1.53],0.4716690260278129
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,13509,56,1.04 [0.75-1.44],0.7939258637376088
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",11388,50,0.82 [0.38-1.80],0.6275200969976891
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,11359,47,0.72 [0.36-1.47],0.369605843335908
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,11468,50,1.25 [0.95-1.66],0.1106262453062419
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,11700,50,1.08 [0.75-1.56],0.6772402652935021
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,13519,56,1.11 [0.70-1.75],0.6572853894276762
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,11717,49,1.58 [0.98-2.55],0.0630453035622157
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,13524,56,1.48 [0.73-2.98],0.2746414231242119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,13646,56,1.22 [0.86-1.75],0.2675318816482162
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,13509,56,1.21 [0.88-1.65],0.234581936737711
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,11442,50,1.36 [0.99-1.87],0.0550859757076549
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,11655,49,1.11 [0.86-1.43],0.4115815100432678
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,11296,47,1.06 [0.67-1.68],0.8023785292576888
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,11379,48,1.01 [0.69-1.48],0.9661071220462748
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,13509,56,1.06 [0.80-1.40],0.6780886088855691
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,11639,49,1.21 [0.89-1.65],0.2312471457159992
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,11359,47,1.19 [0.76-1.87],0.4383665776235521
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,11388,50,1.02 [0.73-1.44],0.8922904176685322
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,11703,50,1.35 [0.98-1.88],0.0699251306383215
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,13523,54,0.92 [0.68-1.23],0.5600260625402594
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,13293,54,1.12 [0.79-1.60],0.5151570846737752
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,11359,47,1.26 [0.64-2.48],0.5002400298662673
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,13293,54,1.90 [1.18-3.06],0.0079581597035851
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,11359,47,1.07 [0.65-1.77],0.7765287484692656
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,11376,48,0.87 [0.62-1.23],0.4401001369687022
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,11655,49,0.97 [0.74-1.26],0.79900735611777
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,11388,50,1.75 [0.99-3.08],0.0528798557255631
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,13167,55,1.15 [0.85-1.57],0.3681094173254425
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,11379,48,1.20 [0.70-2.06],0.5022825178587681
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TTN,Titin,11359,47,1.18 [0.84-1.66],0.3281003481231658
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,11593,48,0.64 [0.22-1.83],0.4042768568512828
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,11376,48,0.96 [0.36-2.57],0.9288451524539132
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,11700,50,1.39 [1.02-1.90],0.0369924537562976
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,11468,50,1.10 [0.80-1.51],0.555679337640594
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,13437,55,1.10 [0.84-1.44],0.5034522693138415
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,11505,48,1.02 [0.55-1.92],0.9395708225961732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,13554,56,0.78 [0.32-1.87],0.5771569344910792
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,13653,57,1.22 [0.88-1.70],0.2343680000965385
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,11685,50,1.52 [0.98-2.34],0.0587319387654868
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,11354,47,0.90 [0.65-1.25],0.5273764403613922
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",13524,56,1.17 [0.71-1.91],0.5363220760223859
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,13444,54,1.12 [0.79-1.59],0.5163289228467519
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,13523,54,1.22 [0.52-2.86],0.6402663293155897
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",11388,50,1.12 [0.71-1.76],0.6248748248612088
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,13455,55,0.60 [0.31-1.16],0.1299641961906565
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,11639,49,1.81 [0.89-3.68],0.1039277284551929
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,11721,50,1.40 [0.93-2.12],0.1100093958079907
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,11388,50,1.30 [0.90-1.87],0.1615765034246468
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,11359,47,0.74 [0.35-1.58],0.4351857195204259
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,11450,48,1.14 [0.77-1.69],0.5047047035240934
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,11655,49,1.14 [0.93-1.38],0.2006229736011242
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,11359,47,1.02 [0.78-1.33],0.9099904698748046
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,11359,47,1.42 [0.84-2.41],0.1869996391522788
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,13437,55,1.06 [0.56-2.03],0.8523283874400363
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,13643,57,1.18 [0.75-1.86],0.4737261389232956
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,11388,50,1.76 [0.79-3.93],0.1653215757309185
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,11296,47,1.38 [0.93-2.05],0.1058845236210147
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,11639,49,1.19 [0.59-2.39],0.6252024444660678
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,11721,50,1.06 [0.80-1.40],0.7035822342077052
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,11376,48,0.69 [0.39-1.21],0.1915553784710214
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,11454,50,0.78 [0.42-1.46],0.443288479447637
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,11450,48,1.21 [0.82-1.78],0.3313692678070252
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,11379,48,1.30 [0.94-1.79],0.1114251660620738
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,13455,55,1.11 [0.85-1.45],0.4352629717417844
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,11639,49,1.40 [0.97-2.02],0.0689814910122293
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,11685,50,1.18 [0.66-2.10],0.5734876064861678
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,11359,47,0.89 [0.63-1.27],0.5321243690727553
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,13293,54,1.11 [0.87-1.41],0.4133701070213156
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,13210,53,1.22 [0.82-1.83],0.3260781130535429
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,13293,54,1.05 [0.68-1.61],0.8284709060141562
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,11388,50,1.31 [0.98-1.76],0.0721688648463919
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,13509,56,1.14 [0.86-1.51],0.3715310893525863
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,13270,55,1.54 [0.67-3.57],0.3129410805690488
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,11717,49,1.45 [1.01-2.08],0.0426669520444108
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,13455,55,1.19 [0.37-3.85],0.770072794993155
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,11376,48,1.26 [0.96-1.66],0.0911754422909189
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,13515,56,1.39 [0.58-3.30],0.4596557401198247
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,13653,57,0.83 [0.38-1.82],0.6351876407159431
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,11296,47,1.05 [0.79-1.40],0.7304104425160377
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,13639,57,0.73 [0.47-1.12],0.1478673458991945
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,11388,50,1.70 [0.69-4.19],0.2499769664019843
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,13554,56,1.06 [0.70-1.61],0.7775107629101234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,13659,57,0.67 [0.33-1.34],0.2544428758433111
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,11703,50,2.30 [1.00-5.29],0.050527433057751
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,13293,54,1.12 [0.90-1.40],0.3048694653682119
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,11394,47,1.23 [0.48-3.14],0.6621139809230234
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,11721,50,1.71 [0.85-3.45],0.1318417105796695
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,13455,55,0.75 [0.55-1.02],0.0636448651556935
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,11717,49,0.80 [0.56-1.14],0.2119605179168414
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,13455,55,0.95 [0.57-1.59],0.8466918299280667
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,11468,50,1.29 [0.90-1.86],0.1655845586203139
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,13455,55,1.09 [0.81-1.46],0.587550604613969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,11639,49,1.26 [0.95-1.67],0.1070902005136482
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,13455,55,1.26 [0.93-1.69],0.1309122218049157
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,11639,49,0.85 [0.39-1.84],0.6717630762827065
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,11359,47,1.24 [0.59-2.61],0.5752027652368608
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,11639,49,1.07 [0.64-1.77],0.8050171347492333
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,13501,56,0.52 [0.28-0.97],0.040050115198105
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,13505,54,1.25 [0.87-1.79],0.2203853744990922
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,11685,50,0.99 [0.47-2.07],0.9747285091399072
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,13183,55,1.09 [0.67-1.77],0.7357020083776138
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,11468,50,1.10 [0.61-1.98],0.760443180977944
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,13293,54,0.98 [0.64-1.49],0.906571206637077
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,13653,57,1.10 [0.80-1.52],0.540850813164038
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,13210,53,0.85 [0.40-1.83],0.6808260444945375
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,11450,48,1.19 [0.77-1.84],0.4240073185351766
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,13625,56,0.98 [0.57-1.71],0.9519452837815636
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,11296,47,0.93 [0.64-1.36],0.7231252550718954
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,13386,54,2.09 [1.13-3.86],0.0184596166394102
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,11703,50,1.32 [0.90-1.93],0.1526938975875852
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,13685,57,1.15 [0.84-1.59],0.3832492714601271
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",13524,56,0.54 [0.29-0.99],0.0458541388013659
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,13260,54,0.92 [0.64-1.32],0.6549616572411674
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,13293,54,1.05 [0.81-1.36],0.705568985217732
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,13183,55,1.07 [0.80-1.42],0.6494428409226825
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,11685,50,1.28 [0.94-1.74],0.1216311673375555
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,11388,50,0.80 [0.48-1.33],0.3935526681584955
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,11639,49,0.82 [0.37-1.79],0.6118117316023551
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,11427,49,1.07 [0.66-1.75],0.7803201872443368
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,13627,56,0.99 [0.69-1.42],0.948434092715199
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,12795,50,2.45 [1.36-4.43],0.0029722662541902
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",13400,54,1.47 [0.83-2.61],0.1896867716299028
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",13544,56,1.74 [0.88-3.42],0.1095067318474273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,13646,56,1.45 [0.74-2.85],0.2841769465074962
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,13260,54,0.57 [0.23-1.40],0.2172612208038969
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,13437,55,1.09 [0.71-1.68],0.6856654183421853
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,13646,56,1.09 [0.73-1.61],0.6862287419713348
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,13612,56,0.85 [0.36-1.96],0.6953482468206611
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,11388,50,1.55 [1.02-2.36],0.0420687139120281
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,13554,56,1.09 [0.84-1.42],0.5243127503587683
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,13183,55,1.35 [0.76-2.40],0.3037735810852609
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,11685,50,0.99 [0.34-2.87],0.9900448063621512
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",11655,49,1.29 [1.06-1.58],0.0110721589127529
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,13455,55,1.04 [0.85-1.29],0.6930247241401946
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,11639,49,1.43 [0.67-3.07],0.3545131381204182
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,11359,47,1.03 [0.67-1.60],0.877805400916676
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,13260,54,1.17 [0.88-1.55],0.27370334540476
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,11450,48,1.34 [0.93-1.92],0.1153885799852273
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,11388,50,2.21 [0.97-5.07],0.0598683418044201
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,11388,50,0.73 [0.33-1.59],0.4215579976583647
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,13210,53,1.03 [0.73-1.46],0.8707107185054019
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,13293,54,0.66 [0.33-1.31],0.2363810461706174
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,11359,47,1.05 [0.68-1.62],0.8170341845279064
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,11655,49,1.35 [1.01-1.82],0.0456819020692237
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,11685,50,0.83 [0.33-2.05],0.6832983571327403
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,11388,50,0.83 [0.37-1.86],0.6530270566486804
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,11468,50,1.17 [0.80-1.71],0.4217700257896172
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,11639,49,1.45 [1.14-1.85],0.0022931665869443
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,11655,49,1.28 [0.88-1.85],0.1955274093513029
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,11639,49,1.62 [1.14-2.30],0.0074904122112163
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,11394,47,1.14 [1.01-1.29],0.0363489837889241
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,11296,47,0.74 [0.28-1.97],0.5438026017732984
Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,11376,48,1.16 [0.91-1.46],0.2250234541564772
